205 results on '"Ross FP"'
Search Results
2. PTH Treatment Increases Cortical Bone Mass More in Response to Compression than Tension in Mice.
- Author
-
Rooney AM, McNeill TJ, Ross FP, Bostrom MPG, and van der Meulen MCH
- Subjects
- Mice, Animals, Bone and Bones, Bone Density, Cortical Bone, Tibia physiology, Parathyroid Hormone pharmacology, Anabolic Agents pharmacology
- Abstract
Parathyroid hormone (PTH) is an anabolic osteoporosis treatment that increases bone mass and reduces fracture risk. Clinically, the effects of PTH are site-specific, increasing bone mass more at the spine than the hip and not increasing bone mass at the radius. Differences in local loading environment between the spine, hip, and radius may help explain the variation in efficacy, as PTH and mechanical loading have been shown to synergistically increase bone mass. We hypothesized that differences in loading mode might further explain these variations. Owing to the curvature of the mouse tibia, cyclic compression of the hindlimb causes bending at the tibial midshaft, placing the anterior surface under tension and the posterior surface under compression. We investigated the combination of PTH treatment and tibial loading in an osteoblast-specific estrogen receptor-alpha knockout mouse model of low bone mass (pOC-ERαKO) and their littermate controls (LCs) and analyzed bone morphology in the tensile, compressive, and neutral regions of the tibial midshaft. We also hypothesized that pretreating wild-type C57Bl/6J (WT) mice with PTH prior to mechanical loading would enhance the synergistic anabolic effects. Compression was more anabolic than tension, and PTH enhanced the effect of loading, particularly under compression. PTH pretreatment maintained the synergistic anabolic effect for longer durations than concurrent treatment and loading alone. Together these data provide insights into more effective physical therapy and exercise regimens for patients receiving PTH treatment. © 2022 American Society for Bone and Mineral Research (ASBMR)., (© 2022 American Society for Bone and Mineral Research (ASBMR).)
- Published
- 2023
- Full Text
- View/download PDF
3. Molecular Identification of Spatially Distinct Anabolic Responses to Mechanical Loading in Murine Cortical Bone.
- Author
-
Chlebek C, Moore JA, Ross FP, and van der Meulen MCH
- Subjects
- Humans, Animals, Mice, Female, Cancellous Bone diagnostic imaging, Osteogenesis physiology, Mice, Inbred C57BL, Weight-Bearing physiology, Cortical Bone, Tibia metabolism
- Abstract
Osteoporosis affects over 200 million women worldwide, one-third of whom are predicted to suffer from an osteoporotic fracture in their lifetime. The most promising anabolic drugs involve administration of expensive antibodies. Because mechanical loading stimulates bone formation, our current data, using a mouse model, replicates the anabolic effects of loading in humans and may identify novel pathways amenable to oral treatment. Murine tibial compression produces axially varying deformations along the cortical bone, inducing highest strains at the mid-diaphysis and lowest at the metaphyseal shell. To test the hypothesis that load-induced transcriptomic responses at different axial locations of cortical bone would vary as a function of strain magnitude, we loaded the left tibias of 10-week-old female C57Bl/6 mice in vivo in compression, with contralateral limbs as controls. Animals were euthanized at 1, 3, or 24 hours post-loading or loaded for 1 week (n = 4-5/group). Bone marrow and cancellous bone were removed, cortical bone was segmented into the metaphyseal shell, proximal diaphysis, and mid-diaphysis, and load-induced differential gene expression and enriched biological processes were examined for the three segments. At each time point, the mid-diaphysis (highest strain) had the greatest transcriptomic response. Similarly, biological processes regulating bone formation and turnover increased earlier and to the greatest extent at the mid-diaphysis. Higher strain induced greater levels of osteoblast and osteocyte genes, whereas expression was lower in osteoclasts. Among the top differentially expressed genes at 24-hours post-loading, 17 had known functions in bone biology, of which 12 were present only in osteoblasts, 3 exclusively in osteoclasts, and 2 were present in both cell types. Based on these results, we conclude that murine tibial loading induces spatially unique transcriptomic responses correlating with strain magnitude in cortical bone. © 2022 American Society for Bone and Mineral Research (ASBMR)., (© 2022 American Society for Bone and Mineral Research (ASBMR).)
- Published
- 2022
- Full Text
- View/download PDF
4. Bone mass and adaptation to mechanical loading are sexually dimorphic in adult osteoblast-specific ERα knockout mice.
- Author
-
Rooney AM, Ayobami OO, Kelly NH, Schimenti JC, Ross FP, and van der Meulen MCH
- Subjects
- Animals, Bone Density, Female, Male, Mice, Mice, Knockout, Osteocytes, Estrogen Receptor alpha genetics, Osteoblasts physiology
- Abstract
Estrogen receptor-alpha (ERα) regulates bone mass and is implicated in bone tissue's response to mechanical loading. The effects of ERα deletion in mice depend on sex, anatomical location, and the cellular stage at which ERα is removed. Few studies have investigated the effect of age on the role of ERα in skeletal maintenance and functional adaptation. We previously demonstrated that bone mass and adaptation to loading were altered in growing 10-week-old female and male mice lacking ERα in mature osteoblasts and osteocytes (pOC-ERαKO). Here our goal was to determine the effects of ERα and mechanical loading in skeletally-mature adult mice. We subjected 26-week-old skeletally-mature adult pOC-ERαKO and littermate control (LC) mice of both sexes to two weeks of in vivo cyclic tibial loading. ERα deletion in male mice did not alter bone mass or the response to loading. Adult female pOC-ERαKO mice had reduced cancellous and cortical bone mass and increased adaptation to high-magnitude mechanical loading compared to LC mice. Thus, ERα deletion from mature osteoblasts reduced the bone mass and increased the mechanoadaptation of adult female but not male mice. Additionally, compared to our previous work in young mice, adult female mice had greatly reduced mechanoadaptation and adult male mice retained most of their mechanoadaptation with age., (Copyright © 2022 Elsevier Inc. All rights reserved.)
- Published
- 2022
- Full Text
- View/download PDF
5. Low bone mass resulting from impaired estrogen signaling in bone increases severity of load-induced osteoarthritis in female mice.
- Author
-
Ziemian SN, Ayobami OO, Rooney AM, Kelly NH, Holyoak DT, Ross FP, and van der Meulen MCH
- Subjects
- Animals, Bone Density, Bone and Bones, Disease Models, Animal, Estrogens, Female, Mice, Tibia diagnostic imaging, Cartilage, Articular, Osteoarthritis
- Abstract
Objective: Reduced subchondral bone mass and increased remodeling are associated with early stage OA. However, the direct effect of low subchondral bone mass on the risk and severity of OA development is unclear. We sought to determine the role of low bone mass resulting from a bone-specific loss of estrogen signaling in load-induced OA development using female osteoblast-specific estrogen receptor-alpha knockout (pOC-ERαKO) mice., Methods: Osteoarthritis was induced by cyclic mechanical loading applied to the left tibia of 26-week-old female pOC-ERαKO and littermate control mice at peak loads of 6.5N, 7N, or 9N for 2 weeks. Cartilage damage and thickness, osteophyte development, and joint capsule fibrosis were assessed from histological sections. Subchondral bone morphology was analyzed by microCT. The correlation between OA severity and intrinsic bone parameters was determined., Results: The loss of ERα in bone resulted in an osteopenic subchondral bone phenotype, but did not directly affect cartilage health. Following two weeks of cyclic tibial loading to induce OA pathology, pOC-ERαKO mice developed more severe cartilage damage, larger osteophytes, and greater joint capsule fibrosis compared to littermate controls. Intrinsic bone parameters negatively correlated with measures of OA severity in loaded limbs., Conclusions: Subchondral bone osteopenia resulting from bone-specific loss of estrogen signaling was associated with increased severity of load-induced OA pathology, suggesting that reduced subchondral bone mass directly exacerbates load-induced OA development. Bone-specific changes associated with estrogen loss may contribute to the increased incidence of OA in post-menopausal women., (Copyright © 2021. Published by Elsevier Inc.)
- Published
- 2021
- Full Text
- View/download PDF
6. Systemic osteoprotegerin does not improve peri-implant bone volume or osseointegration in rabbits.
- Author
-
Choi JH, Wang Z, Ross FP, van der Meulen MCH, and Bostrom MPG
- Subjects
- Animals, Humans, Osteoclasts, Parathyroid Hormone, Prostheses and Implants, RANK Ligand pharmacology, Rabbits, Osseointegration, Osteoprotegerin
- Abstract
Anti-RANKL (receptor activator of nuclear factor kappa-B ligand) agents function by blocking the differentiation of osteoclasts, thereby proving useful in the clinical management of postmenopausal osteoporosis. The effects of such agents on osseointegration is less well understood. The purpose of the current study was to investigate whether osteoprotegerin (OPG), an osteoclast inhibitor, enhances the known anabolic effects of mechanical loading (VEH) and intermittent PTH (iPTH) using a well-established rabbit model of osseointegration. In the first set of experiments, OPG was administered either alone or combined with iPTH to study its effects on measured bone mass. The second set of experiments was conducted using a higher dosage of OPG (10 mg/kg) to explore its early impact at the cellular and molecular levels. All subjects had mechanical load applied to the implant on one extremity, and no load applied on the contralateral side. In the first set of experiments, OPG alone decreased peri-implant bone mass compared to the mechanical loading group, whereas OPG + iPTH increased peri-implant bone mass compared to the OPG group. In the second set of experiments, high-dose OPG significantly decreased osteoclast number (-74.3%) at 1 week. However, this effect was not sustained as osteoclast number returned to baseline by 2 weeks. These results suggest that systemic administration of OPG does not enhance osseointegration, but rather has a detrimental effect., (© 2020 Orthopaedic Research Society. Published by Wiley Periodicals LLC.)
- Published
- 2021
- Full Text
- View/download PDF
7. Correction to: Mechanically Induced Periprosthetic Osteolysis: A Systematic Review.
- Author
-
McArthur BA, Scully R, Ross FP, Bostrom MPG, and Fahlgren A
- Abstract
[This corrects the article DOI: 10.1007/s11420-018-9641-5.]., (© Hospital for Special Surgery 2019.)
- Published
- 2020
- Full Text
- View/download PDF
8. Disruption of the Gut Microbiome Increases the Risk of Periprosthetic Joint Infection in Mice.
- Author
-
Hernandez CJ, Yang X, Ji G, Niu Y, Sethuraman AS, Koressel J, Shirley M, Fields MW, Chyou S, Li TM, Luna M, Callahan RL, Ross FP, Lu TT, Brito IL, Carli AV, and Bostrom MPG
- Subjects
- Animals, Disease Models, Animal, Mice, Gastrointestinal Microbiome physiology, Joint Prosthesis adverse effects, Prosthesis-Related Infections etiology, Staphylococcal Infections etiology, Staphylococcus aureus, Tibia surgery
- Abstract
Background: Periprosthetic joint infection (PJI) is one of the most devastating complications of total joint arthroplasty. Given the mortality and morbidity associated with PJI and the challenges in treating it, there has been increased interest in risk factors that can be modified before surgery. In this study, we used a novel mouse model to consider the role of the gut microbiome as a risk factor for PJI., Questions/purposes: (1) Does the state of the gut microbiota before surgery influence the likelihood of developing an established infection in a mouse model of PJI? (2) How does the state of the gut microbiota before surgery influence the local and systemic response to the presence of an established infection in a mouse model of PJI?, Methods: Male C57Bl/6 mice were divided into two groups: those with modified microbiome [INCREMENT]microbiome (n = 40) and untreated mice (n = 42). In [INCREMENT]microbiome mice, the gut flora were modified using oral neomycin and ampicillin from 4 weeks to 16 weeks of age. Mice received a titanium tibial implant to mimic a joint implant and a local inoculation of Staphylococcus aureus in the synovial space (10 colony forming units [CFUs]). The proportion of animals developing an established infection in each group was determined by CFU count. The local and systemic response to established infection was determined using CFU counts in surrounding joint tissues, analysis of gait, radiographs, body weight, serum markers of inflammation, and immune cell profiles and was compared with animals that received the inoculation but resisted infection., Results: A greater proportion of animals with disrupted gut microbiota had infection (29 of 40 [73%]) than did untreated animals (21 of 42 [50%]; odds ratio, 2.63, 95% CI, 1.04-6.61; p = 0.035). The immune response to established infection in mice with altered microbiota was muted; serum amyloid A, a marker of systemic infection in mice, was greater than in mice with disrupted gut microbiota with infection (689 µg/dL; range, 68-2437 µg/dL, p < 0.05); infection associated increases in monocytes and neutrophils in the spleen and local lymph node in untreated mice but not were not observed in mice with disrupted gut microbiota., Conclusions: The findings from this in vivo mouse model suggest that the gut microbiota may influence susceptibility to PJI., Clinical Relevance: These preclinical findings support the idea that the state of the gut microbiome before surgery may influence the development of PJI and justify further preclinical and clinical studies to develop appropriate microbiome-based interventions.
- Published
- 2019
- Full Text
- View/download PDF
9. New Innovations in the Treatment of PJI and Biofilms-Clinical and Preclinical Topics.
- Author
-
Taha M, Abdelbary H, Ross FP, and Carli AV
- Abstract
Purpose of Review: Periprosthetic joint infection (PJI) is a devastating complication after total joint replacement. A main source for antibiotic tolerance and treatment failure is bacterial production of biofilm-a resilient barrier against antibiotics, immune system, and mechanical debridement. The purpose of this review is to explore some novel approaches to treat PJI and biofilm-related infections., Recent Findings: Innovative treatment strategies of bacterial and biofilm infections revolve around (a) augmenting current therapies, such as improving the delivery and efficiency of conventional antibiotics and enhancing the efficacy of antiseptics and (b) administrating completely new therapeutic modalities, such as using immunotherapy, nanoparticles, lytic bacteriophages, photodynamic therapy, novel antibiotics, and antimicrobial peptides. Several promising treatment strategies for PJI are available to be tested further. The next requirement for most of the novel treatments is reproducing their effects in clinically representative animal models of PJI against clinical isolates of relevant bacteria.
- Published
- 2018
- Full Text
- View/download PDF
10. Vancomycin-Loaded Polymethylmethacrylate Spacers Fail to Eradicate Periprosthetic Joint Infection in a Clinically Representative Mouse Model.
- Author
-
Carli AV, Bhimani S, Yang X, de Mesy Bentley KL, Ross FP, and Bostrom MPG
- Subjects
- Animals, Anti-Bacterial Agents administration & dosage, Bone Cements, Mice, Models, Animal, Polymethyl Methacrylate therapeutic use, Prosthesis-Related Infections microbiology, Staphylococcal Infections microbiology, Vancomycin administration & dosage, Anti-Bacterial Agents therapeutic use, Prosthesis-Related Infections drug therapy, Staphylococcal Infections drug therapy, Staphylococcus aureus, Vancomycin therapeutic use
- Abstract
Background: Periprosthetic joint infection (PJI) remains a devastating complication following total joint arthroplasty. Current animal models of PJI do not effectively recreate the clinical condition and thus provide limited help in understanding why treatments fail. We developed a mouse model of the first-stage surgery of a 2-stage revision for PJI involving a 3-dimensionally printed Ti-6Al-4V implant and a mouse-sized cement spacer that elutes vancomycin., Methods: Vancomycin was mixed with polymethylmethacrylate (PMMA) cement and inserted into custom-made mouse-sized spacer molds. Twenty C57BL/6 mice received a proximal tibial implant and an intra-articular injection of 3 × 10 colony-forming units of Staphylococcus aureus Xen36. At 2 weeks, 9 mice underwent irrigation and debridement of the leg with revision of the implant to an articulating vancomycin-loaded PMMA spacer. Postoperatively, mice underwent radiography and serum inflammatory-marker measurements. Following euthanasia of the mice at 6 weeks, bone and soft tissues were homogenized to quantify bacteria within periprosthetic tissues. Implants and articulating spacers were either sonicated to quantify adherent bacteria or examined under scanning electron microscopy (SEM) to characterize the biofilm., Results: Vancomycin-loaded PMMA spacers eluted vancomycin for ≤144 hours and retained antimicrobial activity. Control mice had elevated levels of inflammatory markers, radiographic evidence of septic loosening of the implant, and osseous destruction. Mice treated with a vancomycin-loaded PMMA spacer had significantly lower levels of inflammatory markers (p < 0.01), preserved tibial bone, and no intra-articular purulence. Retrieved vancomycin-loaded spacers exhibited significantly lower bacterial counts compared with implants (p < 0.001). However, bacterial counts in periprosthetic tissue did not significantly differ between the groups. SEM identified S. aureus encased within biofilm on control implants, while vancomycin-loaded spacers contained no bacteria., Conclusions: This animal model is a clinically representative model of PJI treatment. The results suggest that the antimicrobial effects of PMMA spacers are tightly confined to the articular space and must be utilized in conjunction with thorough tissue debridement and systemic antibiotics., Clinical Relevance: These data provide what we believe to be the first insight into the effect of antibiotic-loaded cement spacers in a clinically relevant animal model and justify the adjunctive use of intravenous antibiotics when performing a 2-stage revision for PJI.
- Published
- 2018
- Full Text
- View/download PDF
11. Selected Heat-Sensitive Antibiotics Are Not Inactivated During Polymethylmethacrylate Curing and Can Be Used in Cement Spacers for Periprosthetic Joint Infection.
- Author
-
Carli AV, Sethuraman AS, Bhimani SJ, Ross FP, and Bostrom MPG
- Subjects
- Arthritis, Infectious surgery, Ceftazidime administration & dosage, Femur, Hot Temperature, Humans, Prosthesis-Related Infections surgery, Silicones, Staphylococcus aureus, Temperature, Anti-Bacterial Agents administration & dosage, Arthritis, Infectious drug therapy, Bone Cements, Polymethyl Methacrylate chemistry, Prosthesis-Related Infections drug therapy, Staphylococcal Infections drug therapy, Vancomycin administration & dosage
- Abstract
Background: Antibiotic use in polymethylmethacrylate (PMMA) spacers has historically been limited to those which are "heat-stable" and thus retain their antimicrobial properties after exposure to the high temperatures which occur during PMMA curing., Methods: This study examines the requirement of "heat stability" by measuring temperatures of Palacos and Simplex PMMA as they cure inside commercial silicone molds of the distal femur and proximal tibia. Temperature probes attached to thermocouples were placed at various depths inside the molds and temperatures were recorded for 20 minutes after PMMA introduced and a temperature curve for each PMMA product was determined. A "heat-stable" antibiotic, vancomycin, and a "heat-sensitive" antibiotic, ceftazidime, were placed in a programmable thermocycler and exposed to the same profile of PMMA curing temperatures. Antimicrobial activity against Staphylococcus aureus was compared for heat-treated antibiotics vs room temperature controls., Results: Peak PMMA temperatures were significantly higher in tibial (115.2°C) vs femoral (85.1°C; P < .001) spacers. In the hottest spacers, temperatures exceeded 100°C for 3 minutes. Simplex PMMA produced significantly higher temperatures (P < .05) compared with Palacos. Vancomycin bioactivity did not change against S aureus with heat exposure. Ceftazidime bioactivity did not change when exposed to femoral temperature profiles and was reduced only 2-fold with tibial profiles., Conclusion: The curing temperatures of PMMA in knee spacers are not high enough or maintained long enough to significantly affect the antimicrobial efficacy of ceftazidime, a known "heat-sensitive" antibiotic. Future studies should investigate if more "heat-sensitive" antibiotics could be used clinically in PMMA spacers., (Copyright © 2018 Elsevier Inc. All rights reserved.)
- Published
- 2018
- Full Text
- View/download PDF
12. GSK-3β inhibition suppresses instability-induced osteolysis by a dual action on osteoblast and osteoclast differentiation.
- Author
-
Amirhosseini M, Madsen RV, Escott KJ, Bostrom MP, Ross FP, and Fahlgren A
- Subjects
- Alkaline Phosphatase genetics, Alkaline Phosphatase metabolism, Animals, Bone Morphogenetic Protein 2 genetics, Bone Morphogenetic Protein 2 metabolism, Bone Plates, Cell Proliferation drug effects, Collagen Type I genetics, Collagen Type I metabolism, Collagen Type I, alpha 1 Chain, Core Binding Factor Alpha 1 Subunit genetics, Core Binding Factor Alpha 1 Subunit metabolism, Disease Models, Animal, Gene Expression Regulation, Glycogen Synthase Kinase 3 beta metabolism, Male, Osteoblasts enzymology, Osteoblasts pathology, Osteoclasts enzymology, Osteoclasts pathology, Osteolysis enzymology, Osteolysis genetics, Osteolysis pathology, Osteoprotegerin genetics, Osteoprotegerin metabolism, Prosthesis Implantation instrumentation, RANK Ligand genetics, RANK Ligand metabolism, RNA, Messenger genetics, RNA, Messenger metabolism, Rats, Sprague-Dawley, Tartrate-Resistant Acid Phosphatase blood, Tibia enzymology, Tibia pathology, Tibia surgery, Time Factors, Transcription Factors genetics, Transcription Factors metabolism, Wnt Signaling Pathway drug effects, beta Catenin genetics, beta Catenin metabolism, Cell Differentiation drug effects, Glycogen Synthase Kinase 3 beta antagonists & inhibitors, Osteoblasts drug effects, Osteoclasts drug effects, Osteogenesis drug effects, Osteolysis prevention & control, Prosthesis Failure, Protein Kinase Inhibitors pharmacology, Tibia drug effects
- Abstract
Currently, there are no medications available to treat aseptic loosening of orthopedic implants. Using osteoprotegerin fusion protein (OPG-Fc), we previously blocked instability-induced osteoclast differentiation and peri-prosthetic osteolysis. Wnt/β-catenin signaling, which regulates OPG secretion from osteoblasts, also modulates the bone tissue response to mechanical loading. We hypothesized that activating Wnt/β-catenin signaling by inhibiting glycogen synthase kinase-3β (GSK-3β) would reduce instability-induced bone loss through regulation of both osteoblast and osteoclast differentiation. We examined effects of GSK-3β inhibition on regulation of RANKL and OPG in a rat model of mechanical instability-induced peri-implant osteolysis. The rats were treated daily with a GSK-3β inhibitor, AR28 (20 mg/kg bw), for up to 5 days. Bone tissue and blood serum were assessed by qRT-PCR, immunohistochemistry, and ELISA on days 3 and 5, and by micro-CT on day 5. After 3 days of treatment with AR28, mRNA levels of β-catenin, Runx2, Osterix, Col1α1, and ALP were increased leading to higher osteoblast numbers compared to vehicle-treated animals. BMP-2 and Wnt16 mRNA levels were downregulated by mechanical instability and this was rescued by GSK-3β inhibition. Osteoclast numbers were decreased significantly after 3 days of GSK-3β inhibition, which correlated with enhanced OPG mRNA expression. This was accompanied by decreased serum levels of TRAP5b on days 3 and 5. Treatment with AR28 upregulated osteoblast differentiation, while osteoclastogenesis was blunted, leading to increased bone mass by day 5. These data suggest that GSK-3β inactivation suppresses osteolysis through regulating both osteoblast and osteoclast differentiation in a rat model of instability-induced osteolysis., (© 2017 Wiley Periodicals, Inc.)
- Published
- 2018
- Full Text
- View/download PDF
13. Def6 Restrains Osteoclastogenesis and Inflammatory Bone Resorption.
- Author
-
Binder N, Miller C, Yoshida M, Inoue K, Nakano S, Hu X, Ivashkiv LB, Schett G, Pernis A, Goldring SR, Ross FP, and Zhao B
- Subjects
- Actins metabolism, Animals, Arthritis, Rheumatoid genetics, Autocrine Communication, Bone Resorption genetics, Cell Differentiation genetics, Cells, Cultured, DNA-Binding Proteins genetics, Disease Models, Animal, Guanine Nucleotide Exchange Factors, Humans, Mice, Mice, Inbred C57BL, Mice, Knockout, Nuclear Proteins genetics, Osteolysis genetics, RANK Ligand immunology, Arthritis, Rheumatoid metabolism, Bone Resorption immunology, DNA-Binding Proteins metabolism, Macrophages physiology, Nuclear Proteins metabolism, Osteoclasts physiology, Osteogenesis genetics, Osteolysis immunology
- Abstract
Inflammatory bone resorption mediated by osteoclasts is a major cause of morbidity and disability in many inflammatory disorders, including rheumatoid arthritis (RA). The mechanisms that regulate osteoclastogenesis and bone resorption in inflammatory settings are complex and have not been well elucidated. In this study, we identify the immunoregulator differentially expressed in FDCP 6 homolog (Def6) as a novel inhibitor of osteoclastogenesis in physiological and inflammatory conditions. Def6 deficiency in Def6
-/- mice enhanced the sensitivity of osteoclast precursors to the physiological osteoclastogenic inducer receptor activator for NF-κB ligand, and Def6-/- osteoclasts formed actin rings. Furthermore, Def6 deficiency markedly increased TNF-α-induced osteoclastogenesis in vitro and in vivo and enhanced bone resorption in an inflammatory osteolysis mouse model. TNF-α serum levels correlated negatively with Def6 expression levels in osteoclast precursors obtained from RA patients, and the osteoclastogenic capacity of the osteoclast precursors was significantly inversely correlated with their Def6 expression levels, indicating that Def6 functions as an inhibitor of excessive osteoclast formation and bone destruction in RA. Mechanistically, Def6 suppressed osteoclastogenesis and the expression of key osteoclastogenic factors NFATc1, B lymphocyte-induced maturation protein-1, and c-Fos by regulating an endogenous IFN-β-mediated autocrine feedback loop. The Def6-dependent pathway may represent a novel therapeutic target to prevent pathological bone destruction., (Copyright © 2017 by The American Association of Immunologists, Inc.)- Published
- 2017
- Full Text
- View/download PDF
14. Quantification of Peri-Implant Bacterial Load and in Vivo Biofilm Formation in an Innovative, Clinically Representative Mouse Model of Periprosthetic Joint Infection.
- Author
-
Carli AV, Bhimani S, Yang X, Shirley MB, de Mesy Bentley KL, Ross FP, and Bostrom MP
- Subjects
- Animals, Bacterial Load, Disease Models, Animal, Knee Joint diagnostic imaging, Mice, Prosthesis-Related Infections diagnostic imaging, Radiography, Biofilms, Knee Joint microbiology, Prostheses and Implants microbiology, Prosthesis-Related Infections microbiology, Staphylococcal Infections microbiology, Staphylococcus aureus isolation & purification
- Abstract
Background: Periprosthetic joint infection (PJI) is a devastating complication following total joint arthroplasty. Current animal models of PJI are limited because of a lack of quantitative methods and failure to effectively recreate the periprosthetic space. We therefore developed a murine PJI model involving a 3-dimensionally printed Ti-6Al-4V implant capable of bearing weight and permitting quantitative analysis of periprosthetic bacterial load and evaluation of biofilm., Methods: Twenty-five 12-week-old C57BL/6 mice received a unilateral proximal tibial implant and intra-articular injection of either 3 × 10 colony forming units (CFUs) of Staphylococcus aureus Xen 36 or saline solution. Postoperatively, mice underwent gait analysis, knee radiographs, and serum inflammatory marker measurements. Following euthanasia at 2 or 6 weeks, bone and soft tissues were homogenized to quantify bacteria within periprosthetic tissues. Implants were either sonicated to quantify adherent bacteria or examined under scanning electron microscopy (SEM) to characterize biofilm., Results: All mice survived surgery and were not systemically septic. The control mice immediately tolerated weight-bearing and had normal inflammatory markers and radiographic signs of osseointegration. Infected mice had difficulty walking over time, exhibited radiographic findings of septic implant loosening, and had significantly elevated inflammatory markers. Periprosthetic tissues of the infected animals displayed a mean of 4.46 × 10 CFUs of S. aureus at 2 weeks and 2.53 × 10 CFUs at 6 weeks. Viable S. aureus was quantified on retrieved implant surfaces. SEM demonstrated S. aureus cocci in clusters encased within biofilm., Conclusions: This animal model is, to our knowledge, the most clinically representative PJI replication to date. It is the first that we know of to produce infection through the same method hypothesized to occur clinically, utilize a weight-bearing implant that can osseointegrate, and provide quantitative data on 8 aspects of PJI, including radiographic features, inflammatory markers, and bacterial loads., Clinical Relevance: This novel animal model is, to our knowledge, the first to provide a load-bearing translational representation of clinical PJI that effectively recreates the periprosthetic space.
- Published
- 2017
- Full Text
- View/download PDF
15. Developing a Clinically Representative Model of Periprosthetic Joint Infection.
- Author
-
Carli AV, Ross FP, Bhimani SJ, Nodzo SR, and Bostrom MP
- Subjects
- Animals, Humans, Mice, Rabbits, Disease Models, Animal, Prosthesis-Related Infections surgery
- Abstract
➤The poor treatment outcomes for periprosthetic joint infection (PJI) reflect the limited understanding that currently exists regarding the pathogenesis of this devastating clinical problem.➤Current animal models of PJI are limited in their translational nature primarily because of their inability to recreate the periprosthetic environment.➤A greater mechanistic understanding of the musculoskeletal and immune systems of small animals, such as mice and rats, provides a more robust platform for modeling and examining the pathogenesis of PJI.➤A clinically representative PJI model must involve an implant that recreates the periprosthetic space and be amenable to methodologies that identify implant biofilm as well as quantify the peri-implant bacterial load., (Copyright © 2016 by The Journal of Bone and Joint Surgery, Incorporated.)
- Published
- 2016
- Full Text
- View/download PDF
16. Transcriptional profiling of cortical versus cancellous bone from mechanically-loaded murine tibiae reveals differential gene expression.
- Author
-
Kelly NH, Schimenti JC, Ross FP, and van der Meulen MC
- Subjects
- Animals, Female, Mice, Inbred C57BL, Muscles metabolism, Real-Time Polymerase Chain Reaction, Reproducibility of Results, Sequence Analysis, RNA, Tibia physiology, Time Factors, Weight-Bearing, Wnt Signaling Pathway genetics, Cancellous Bone metabolism, Cortical Bone metabolism, Gene Expression Profiling, Gene Expression Regulation, Stress, Mechanical, Tibia metabolism, Transcription, Genetic
- Abstract
Mechanical loading is an anabolic stimulus that increases bone mass, and thus a promising method to counteract osteoporosis-related bone loss. The mechanism of this anabolism remains unclear, and needs to be established for both cortical and cancellous envelopes individually. We hypothesized that cortical and cancellous bone display different gene expression profiles at baseline and in response to mechanical loading. To test this hypothesis, the left tibiae of 10-week-old female C57Bl/6 mice were subjected to one session of axial tibial compression (9N, 1200cycles, 4Hz triangle waveform) and euthanized 3 and 24h following loading. The right limb served as the contralateral control. We performed RNA-seq on marrow-free metaphyseal samples from the cortical shell and the cancellous core to determine differential gene expression at baseline (control limb) and in response to load. Differential expression was verified with qPCR. Cortical and cancellous bone exhibited distinctly different transcriptional profiles basally and in response to mechanical loading. More genes were differentially expressed with loading at 24h with more genes downregulated at 24h than at 3h in both tissues. Enhanced Wnt signaling dominated the response in cortical bone at 3 and 24h, but in cancellous bone only at 3h. In cancellous bone at 24h many muscle-related genes were downregulated. These findings reveal key differences between cortical and cancellous genetic regulation in response to mechanical loading. Future studies at different time points and multiple loading sessions will add to our knowledge of cortical and cancellous mechanotransduction with the potential to identify new targets for mouse genetic knockout studies and drugs to treat osteoporosis., (Copyright © 2016 Elsevier Inc. All rights reserved.)
- Published
- 2016
- Full Text
- View/download PDF
17. Effects of Deletion of ERα in Osteoblast-Lineage Cells on Bone Mass and Adaptation to Mechanical Loading Differ in Female and Male Mice.
- Author
-
Melville KM, Kelly NH, Surita G, Buchalter DB, Schimenti JC, Main RP, Ross FP, and van der Meulen MC
- Subjects
- Animals, Female, Lumbar Vertebrae pathology, Male, Mice, Mice, Knockout, Organ Size, Osteoblasts pathology, Osteocalcin genetics, Osteocalcin metabolism, Osteocytes metabolism, Tibia pathology, Adaptation, Physiological, Estrogen Receptor alpha deficiency, Lumbar Vertebrae metabolism, Osteoblasts metabolism, Sex Characteristics, Tibia metabolism
- Abstract
Estrogen receptor alpha (ERα) has been implicated in bone's response to mechanical loading in both males and females. ERα in osteoblast lineage cells is important for determining bone mass, but results depend on animal sex and the cellular stage at which ERα is deleted. We demonstrated previously that when ERα is deleted from mature osteoblasts and osteocytes in mixed-background female mice, bone mass and strength are decreased. However, few studies exist examining the skeletal response to loading in bone cell-specific ERαKO mice. Therefore, we crossed ERα floxed (ERα(fl/fl)) and osteocalcin-Cre (OC-Cre) mice to generate animals lacking ERα in mature osteoblasts and osteocytes (pOC-ERαKO) and littermate controls (LC). At 10 weeks of age, the left tibia was loaded in vivo for 2 weeks. We analyzed bone mass through micro-CT, bone formation rate by dynamic histomorphometry, bone strength from mechanical testing, and osteoblast and osteoclast activity by serum chemistry and immunohistochemistry. ERα in mature osteoblasts differentially regulated bone mass in males and females. Compared with LC, female pOC-ERαKO mice had decreased cortical and cancellous bone mass, whereas male pOC-ERαKO mice had equal or greater bone mass than LC. Bone mass results correlated with decreased compressive strength in pOC-ERαKO female L(5) vertebrae and with increased maximum moment in pOC-ERαKO male femora. Female pOC-ERαKO mice responded more to mechanical loading, whereas the response of pOC-ERαKO male animals was similar to their littermate controls., (© 2015 American Society for Bone and Mineral Research.)
- Published
- 2015
- Full Text
- View/download PDF
18. Intermittent Parathyroid Hormone Enhances Cancellous Osseointegration of a Novel Murine Tibial Implant.
- Author
-
Yang X, Ricciardi BF, Dvorzhinskiy A, Brial C, Lane Z, Bhimani S, Burket JC, Hu B, Sarkisian AM, Ross FP, van der Meulen MC, and Bostrom MP
- Subjects
- Animals, Drug Administration Schedule, Female, Injections, Subcutaneous, Mice, Mice, Inbred C57BL, Photomicrography, Prosthesis Design, Tibia physiology, Tibia surgery, Titanium, Bone Density Conservation Agents administration & dosage, Joint Prosthesis, Models, Animal, Osseointegration drug effects, Parathyroid Hormone administration & dosage, Prosthesis Implantation, Tibia drug effects
- Abstract
Background: Long-term fixation of uncemented joint implants requires early mechanical stability and implant osseointegration. To date, osseointegration has been unreliable and remains a major challenge in cementless total knee arthroplasty. We developed a murine model in which an intra-articular proximal tibial titanium implant with a roughened stem can be loaded through the knee joint. Using this model, we tested the hypothesis that intermittent injection of parathyroid hormone (iPTH) would increase proximal tibial cancellous osseointegration., Methods: Ten-week-old female C57BL/6 mice received a subcutaneous injection of PTH (40 μg/kg/day) or a vehicle (n = 45 per treatment group) five days per week for six weeks, at which time the baseline group was killed (n = 6 per treatment group) and an implant was inserted into the proximal part of the tibiae of the remaining mice. Injections were continued until the animals were killed at one week (n = 7 per treatment group), two weeks (n = 14 per treatment group), or four weeks (n = 17 per treatment group) after implantation. Outcomes included peri-implant bone morphology as analyzed with micro-computed tomography (microCT), osseointegration percentage and bone area fraction as shown with backscattered electron microscopy, cellular composition as demonstrated by immunohistochemical analysis, and pullout strength as measured with mechanical testing., Results: Preimplantation iPTH increased the epiphyseal bone volume fraction by 31.6%. When the data at post-implantation weeks 1, 2, and 4 were averaged for the iPTH-treated mice, the bone volume fraction was 74.5% higher in the peri-implant region and 168% higher distal to the implant compared with the bone volume fractions in the same regions in the vehicle-treated mice. Additionally, the trabecular number was 84.8% greater in the peri-implant region and 74.3% greater distal to the implant. Metaphyseal osseointegration and bone area fraction were 28.1% and 70.1% higher, respectively, in the iPTH-treated mice than in the vehicle-treated mice, and the maximum implant pullout strength was 30.9% greater. iPTH also increased osteoblast and osteoclast density by 65.2% and 47.0%, respectively, relative to the values in the vehicle group, when the data at post-implantation weeks 1 and 2 were averaged., Conclusions: iPTH increased osseointegration, cancellous mass, and the strength of the bone-implant interface., Clinical Relevance: Our murine model is an excellent platform on which to study biological enhancement of cancellous osseointegration., (Copyright © 2015 by The Journal of Bone and Joint Surgery, Incorporated.)
- Published
- 2015
- Full Text
- View/download PDF
19. Intermittent PTH administration and mechanical loading are anabolic for periprosthetic cancellous bone.
- Author
-
Grosso MJ, Courtland HW, Yang X, Sutherland JP, Stoner K, Nguyen J, Fahlgren A, Ross FP, van der Meulen MC, and Bostrom MP
- Subjects
- Adipocytes physiology, Animals, Bone and Bones cytology, Combined Modality Therapy, Drug Evaluation, Preclinical, Implants, Experimental, Male, Osteoblasts physiology, Osteogenesis, Prosthesis Failure, Rabbits, Rats, Titanium, Weight-Bearing, Wnt Proteins metabolism, beta Catenin metabolism, Bone and Bones physiology, Osseointegration, Parathyroid Hormone therapeutic use, Periprosthetic Fractures prevention & control
- Abstract
The purpose of this study was to determine the individual and combined effects on periprosthetic cancellous bone of intermittent parathyroid hormone administration (iPTH) and mechanical loading at the cellular, molecular, and tissue levels. Porous titanium implants were inserted bilaterally on the cancellous bone of adult rabbits beneath a loading device attached to the distal lateral femur. The left femur received a sham loading device. The right femur was loaded daily, and half of the rabbits received daily PTH. Periprosthetic bone was evaluated up to 28 days for gene expression, histology, and µCT analysis. Loading and iPTH increased bone mass by a combination of two mechanisms: (1) Altering cell populations in a pro-osteoblastic/anti-adipocytic direction, and (2) controlling bone turnover by modulating the RANKL-OPG ratio. At the tissue level, BV/TV increased with both loading (+53%, p < 0.05) and iPTH (+54%, p < 0.05). Combined treatment showed only small additional effects at the cellular and molecular levels that corresponded to a small additive effect on bone volume (+13% compared to iPTH alone, p > 0.05). This study suggests that iPTH and loading are potential therapies for enhancing periprosthetic bone formation. The elucidation of the cellular and molecular response may help further enhance the combined therapy and related targeted treatment strategies., (© 2014 Orthopaedic Research Society. Published by Wiley Periodicals, Inc.)
- Published
- 2015
- Full Text
- View/download PDF
20. Female mice lacking estrogen receptor-alpha in osteoblasts have compromised bone mass and strength.
- Author
-
Melville KM, Kelly NH, Khan SA, Schimenti JC, Ross FP, Main RP, and van der Meulen MC
- Subjects
- Animals, Bone and Bones pathology, Disease Models, Animal, Estrogen Receptor alpha genetics, Female, Fractures, Bone genetics, Fractures, Bone pathology, Humans, Insulin-Like Growth Factor I genetics, Insulin-Like Growth Factor I metabolism, Mice, Mice, Knockout, Osteoblasts pathology, Osteocalcin genetics, Osteocalcin metabolism, Osteoporosis, Postmenopausal genetics, Osteoporosis, Postmenopausal pathology, Bone and Bones metabolism, Estrogen Receptor alpha metabolism, Fractures, Bone metabolism, Osteoblasts metabolism, Osteoporosis, Postmenopausal metabolism
- Abstract
Reduced bioavailability of estrogen increases skeletal fracture risk in postmenopausal women, but the mechanisms by which estrogen regulates bone mass are incompletely understood. Because estrogen signaling in bone acts, in part, through estrogen receptor alpha (ERα), mice with global deletion of ERα (ERαKO) have been used to determine the role of estrogen signaling in bone biology. These animals, however, have confounding systemic effects arising from other organs, such as increased estrogen and decreased insulin-like growth factor 1 (IGF-1) serum levels, which may independently affect bone. Mice with tissue-specific ERα deletion in chondrocytes, osteoblasts, osteocytes, or osteoclasts lack the systemic effects seen in the global knockout, but show that presence of the receptor is important for the function of each cell type. Although bone mass is reduced when ERα is deleted from osteoblasts, no study has determined if this approach reduces whole bone strength. To address this issue, we generated female osteoblast-specific ERαKO mice (pOC-ERαKO) by crossing mice expressing a floxed ERα gene (ERα(fl/fl)) with mice transgenic for the osteocalcin-Cre promoter (OC-Cre). Having confirmed that serum levels of estrogen and IGF-1 were unaltered, we focused on relating bone mechanics to skeletal phenotype using whole bone mechanical testing, microcomputed tomography, histology, and dynamic histomorphometry. At 12 and 18 weeks of age, pOC-ERαKO mice had decreased cancellous bone mass in the proximal tibia, vertebra, and distal femur, and decreased cortical bone mass in the tibial midshaft, distal femoral cortex, and L5 vertebral cortex. Osteoblast activity was reduced in cancellous bone of the proximal tibia, but osteoclast number was unaffected. Both femora and vertebrae had decreased whole bone strength in mechanical tests to failure, indicating that ERα in osteoblasts is required for appropriate bone mass and strength accrual in female mice. This pOC-ERαKO mouse is an important animal model that could enhance our understanding of estrogen signaling in bone cells in vivo., (© 2014 American Society for Bone and Mineral Research.)
- Published
- 2014
- Full Text
- View/download PDF
21. Targeting the giant cell tumor stromal cell: functional characterization and a novel therapeutic strategy.
- Author
-
Steensma MR, Tyler WK, Shaber AG, Goldring SR, Ross FP, Williams BO, Healey JH, and Purdue PE
- Subjects
- Adolescent, Adult, Aminophenols pharmacology, Aminophenols therapeutic use, Bone Morphogenetic Proteins metabolism, Cell Differentiation drug effects, Cell Separation, Culture Media pharmacology, Female, Giant Cell Tumor of Bone drug therapy, Humans, Ligands, Male, Maleimides pharmacology, Maleimides therapeutic use, Middle Aged, Osteoblasts drug effects, Osteoblasts metabolism, Osteoblasts pathology, Osteoclasts drug effects, Osteoclasts metabolism, Osteoclasts pathology, Osteogenesis drug effects, Osteoprotegerin metabolism, Polymerase Chain Reaction, RANK Ligand metabolism, Stromal Cells, Wnt Signaling Pathway drug effects, Young Adult, Giant Cell Tumor of Bone pathology, Giant Cell Tumor of Bone therapy
- Abstract
Giant cell tumor of bone (GCTB) is a benign, locally destructive neoplasm, with tumors comprised of mesenchymal fibroblast-like stromal cells; monocytic, mononuclear cells of myeloid lineage; and the characteristic osteoclast-like, multinucleated giant cells. Hampering the study of the complex interaction of its constituent cell types is the propensity of longstanding, repeatedly passaged cell cultures to undergo phenotypic alteration and loss of osteoclast-inducing capacities. In this study, we employed a novel, single-step technique to purify freshly harvested stromal cells using a CD14-negative selection column. Using 9 freshly harvested GCTB specimens and the purified stromal cell component, we performed analyses for markers of osteoblast lineage and analyzed the capacity of the stromal cells to undergo osteoblastic differentiation and induce osteoclastogenesis in co-cultures with monocytic cells. Successful purification of the CD14-negative stromal cells was confirmed via flow cytometric analysis and immunocytochemistry. Osteogenic media upregulated the expression of osteocalcin, suggesting an osteoblastic lineage of the GCTB stromal cells. The effects of the Wnt pathway agonist, SB415286, and recombinant human bone morphogenetic protein (BMP)-2 on osteoblastogenesis varied among samples. Notably, osteogenic media and SB415286 reversed the receptor activator of NF-κB ligand (RANKL)/osteoprotegerin (OPG) expression ratio resulting in diminished osteoclastogenic capacity. Recombinant human BMP2 had the opposite effect, resulting in enhanced and sustained support of osteoclastogenesis. Targeting the giant cell tumor stromal cell may be an effective adjunct to existing anti-resorptive strategies.
- Published
- 2013
- Full Text
- View/download PDF
22. Bone remodelling in inflammatory arthritis.
- Author
-
Goldring SR, Purdue PE, Crotti TN, Shen Z, Flannery MR, Binder NB, Ross FP, and McHugh KP
- Subjects
- Humans, Osteoclasts physiology, Arthritis, Rheumatoid physiopathology, Bone Remodeling physiology, Lupus Erythematosus, Systemic physiopathology, Spondylarthropathies physiopathology
- Abstract
The inflammatory arthropathies that include rheumatoid arthritis, the seronegative spondyloarthropathies and systemic lupus erythematosus are characterised by marked alterations in the architecture and structural integrity of peri-articular bone; however, the pattern and natural history of the skeletal changes differs in these conditions. In part, this can be attributed to differences in the primary anatomical site of the inflammation, but also there is evidence that there are differences in the biological properties and products produced by inflammatory tissues. This review will focus on recent advances in the understanding of the cellular and molecular mechanisms that contribute to the differential pattern of articular bone remodelling in these prototypical inflammatory forms of arthritis.
- Published
- 2013
- Full Text
- View/download PDF
23. Orthopedic wear debris mediated inflammatory osteolysis is mediated in part by NALP3 inflammasome activation.
- Author
-
Burton L, Paget D, Binder NB, Bohnert K, Nestor BJ, Sculco TP, Santambrogio L, Ross FP, Goldring SR, and Purdue PE
- Subjects
- Animals, Bone Cements toxicity, Carrier Proteins metabolism, Caspases deficiency, Caspases genetics, Caspases, Initiator, Cells, Cultured, Disease Models, Animal, Humans, Inflammasomes metabolism, Interleukin-1beta metabolism, Macrophage Colony-Stimulating Factor immunology, Macrophage Colony-Stimulating Factor metabolism, Macrophages cytology, Macrophages immunology, Macrophages metabolism, Mice, Mice, Inbred NOD, Mice, Mutant Strains, Monocytes cytology, Monocytes immunology, Monocytes metabolism, NLR Family, Pyrin Domain-Containing 3 Protein, Osteolysis pathology, Phagocytosis drug effects, Phagocytosis immunology, RANK Ligand immunology, RANK Ligand metabolism, Skull cytology, Skull immunology, Arthroplasty, Replacement adverse effects, Carrier Proteins immunology, Inflammasomes immunology, Osteolysis immunology, Polymethyl Methacrylate toxicity, Prosthesis Failure etiology
- Abstract
Activation of myeloid cells by orthopedic particulate debris is a key event in the pathogenesis of periprosthetic osteolysis and implant loosening after total joint replacement (TJR). Several lines of evidence implicate NACHT, LRR, and PYD domains-containing protein 3 (NALP3) inflammasome-mediated production of interleukin 1 beta (IL-1β) in the pathogenesis of clinical disorders ascribable to foreign particulate materials, including asbestos, silica, and urate crystals. Recent reports indicate that orthopedic polymer products and metallic particulates and ions may activate the same pathway. Here, we investigated the contribution of the NALP3 inflammasome to the pathogenesis of peri-implant osteolysis. Pharmaceutical and genetic perturbations of caspase-1 and inflammasome components were used to assess the role of the NALP3 inflammasome in IL-1β production and osteoclast formation by human monocytes and mouse macrophages in response to polymethylmethacrylate (PMMA) particle phagocytosis. The role of caspase-1 in a mouse calvarial model of particle-mediated osteolysis was assessed using µCT. Phagocytosis of PMMA particles induces caspase-1 dependent release of IL-1β from human monocytes and mouse macrophages. Importantly, using macrophages from mice deficient in components of the NALP3 inflammasome, we show PMMA-induced IL-1β production is strictly dependent on these components. Mice lacking caspase-1, the sole effector of the NALP3 inflammasome, show reduced orthopedic wear particle-induced calvarial osteolysis compared to wild-type controls. Absence of NALP3 inflammasome components fails to alter osteoclast formation in vitro. Our findings identify the NALP3 inflammasome as a critical mediator of orthopedic wear-induced osteolysis and as a viable therapeutic target for the treatment of periprosthetic osteolysis., (Copyright © 2012 Orthopaedic Research Society.)
- Published
- 2013
- Full Text
- View/download PDF
24. An ELIXIR for bone loss?
- Author
-
Ross FP
- Subjects
- Animals, Female, Humans, Liver X Receptors, Orphan Nuclear Receptors physiology, Osteoblasts physiology, Osteoclasts physiology
- Published
- 2012
- Full Text
- View/download PDF
25. TREM2 and β-catenin regulate bone homeostasis by controlling the rate of osteoclastogenesis.
- Author
-
Otero K, Shinohara M, Zhao H, Cella M, Gilfillan S, Colucci A, Faccio R, Ross FP, Teitelbaum SL, Takayanagi H, and Colonna M
- Subjects
- Animals, Blotting, Western, Bone and Bones cytology, Cell Proliferation, Female, Fluorescent Antibody Technique, Immunoprecipitation, Mice, Mice, Inbred C57BL, Mice, Knockout, Reverse Transcriptase Polymerase Chain Reaction, Stem Cells cytology, Bone and Bones metabolism, Cell Differentiation physiology, Homeostasis physiology, Membrane Glycoproteins metabolism, Osteoclasts cytology, Receptors, Immunologic metabolism, beta Catenin metabolism
- Abstract
TREM2 is an immunoreceptor expressed on osteoclasts (OC) and microglia that transmits intracellular signals through the adaptor DAP12. Individuals with genetic mutations inactivating TREM2 or DAP12 develop the Nasu-Hakola disease (NHD) with cystic-like lesions of the bone and brain demyelination that lead to fractures and presenile dementia. The mechanisms of this disease are poorly understood. In this study, we report that TREM2-deficient mice have an osteopenic phenotype reminiscent of NHD. In vitro, lack of TREM2 impairs proliferation and β-catenin activation in osteoclast precursors (OcP) in response to M-CSF. This defect results in accelerated differentiation of OcP into mature OC. Corroborating the importance of a balanced proliferation and differentiation of OcP for bone homeostasis, we show that conditional deletion of β-catenin in OcP also results in reduced OcP proliferation and accelerated osteoclastogenesis in vitro as well as osteopenia in vivo. These results reveal that TREM2 regulates the rate of osteoclastogenesis and provide a mechanism for the bone pathology in NHD.
- Published
- 2012
- Full Text
- View/download PDF
26. Comparative proteomic analysis of a cytosolic fraction from β3 integrin-deficient cells.
- Author
-
Bush JA, Kitaura H, Ma Y, Teitelbaum SL, Ross FP, and Smith JW
- Subjects
- Animals, Cathepsin B metabolism, Fibroblasts metabolism, HEK293 Cells, Humans, Isotope Labeling, Mice, Mice, 129 Strain, Mice, Inbred C57BL, Mice, Knockout, Paxillin metabolism, Protein Binding, Proteome genetics, Proteome metabolism, Tandem Mass Spectrometry, Transfection, Cytosol metabolism, Integrin beta3 genetics, Proteomics
- Abstract
Integrins are heterodimeric transmembrane receptors involved in sensing and transmitting informational cues from the extracellular environment to the cell. This study explored sub-proteome changes in response to elimination of the β3 integrin using a knockout murine model. Cleavable isotope-coded affinity tagging (cICAT) in combination with sub-cellular fractionation, multiple dimensions of separation and tandem mass spectrometry (MS/MS) were used to characterize differentially expressed proteins among β3 integrin(-/-) (β3(-/-)) mouse embryonic fibroblasts and isogenic wild-type (WT) controls. From a cytosolic protein fraction, 48 proteins were identified, in which expression differed by > 1.5-fold. Predominant ontological groups included actin-binding/cytoskeletal proteins and protease/protease inhibitors. Interestingly, β3 integrin expression was inversely correlated with expression of cathepsin B, a lysosomal cysteine protease, as its expression was greater by over 3.5-fold in the β3(-/-) cells. This inverse correlation was also observed in stable heterologous cells transfected with β3 integrin, where the intracellular expression and activity of cathepsin B was lower compared to control cells. Our data suggests that the composition of the cellular proteome is influenced by integrin expression patterns and reveals a strong functional relationship between β3 integrin and cathepsin B.
- Published
- 2012
27. Bone matrix regulates osteoclast differentiation and annexin A8 gene expression.
- Author
-
Crotti TN, O'Sullivan RP, Shen Z, Flannery MR, Fajardo RJ, Ross FP, Goldring SR, and McHugh KP
- Subjects
- Actins metabolism, Animals, Annexins genetics, Cell Shape, Cells, Cultured, Cytoskeleton metabolism, Gene Expression Profiling methods, Humans, Immunohistochemistry, Mice, Oligonucleotide Array Sequence Analysis, RNA Interference, RNA, Messenger metabolism, Reverse Transcriptase Polymerase Chain Reaction, Time Factors, Transcription, Genetic, Up-Regulation, Annexins metabolism, Bone Matrix metabolism, Cell Differentiation, Osteoclasts metabolism
- Abstract
While attachment to bone is required for optimal osteoclast function, the molecular events that underlie this fact are unclear, other than that the cell requires adhesion to mineralized matrix to assume a fully differentiated phenotype. To address this issue, we cultured murine bone marrow-derived osteoclasts on either cell culture plastic or devitalized mouse calvariae to identify the distinct genetic profile induced by interaction with bone. Among a number of genes previously unknown to be expressed in osteoclasts we found that Annexin A8 (AnxA8) mRNA was markedly up-regulated by bone. AnxA8 protein was present at high levels in osteoclasts present in human tissues recovered from sites of pathological bone loss. The presence of bone mineral was required for up-regulation of AnxA8 mRNA since osteoclasts plated on decalcified bone express AnxA8 at low levels as did osteoclasts plated on native or denatured type I collagen. Finally, AnxA8-regulated cytoskeletal reorganization in osteoclasts generated on a mineralized matrix. Thus, we used a novel approach to define a distinct bone-dependent genetic program associated with terminal osteoclast differentiation and identified Anxa8 as a gene strongly induced late in osteoclast differentiation and a protein that regulates formation of the cell's characteristic actin ring., (Copyright © 2011 Wiley-Liss, Inc.)
- Published
- 2011
- Full Text
- View/download PDF
28. Rac deletion in osteoclasts causes severe osteopetrosis.
- Author
-
Croke M, Ross FP, Korhonen M, Williams DA, Zou W, and Teitelbaum SL
- Subjects
- Animals, Bone Resorption, Cells, Cultured, Cytoskeleton genetics, Cytoskeleton metabolism, Disease Models, Animal, Female, Humans, Male, Mice, Mice, Inbred C57BL, Mice, Knockout, Osteopetrosis physiopathology, rac GTP-Binding Proteins metabolism, rac1 GTP-Binding Protein metabolism, RAC2 GTP-Binding Protein, Gene Deletion, Osteoclasts enzymology, Osteopetrosis enzymology, Osteopetrosis genetics, rac GTP-Binding Proteins genetics, rac1 GTP-Binding Protein genetics
- Abstract
Cdc42 mediates bone resorption principally by stimulating osteoclastogenesis. Whether its sister GTPase, Rac, meaningfully impacts upon the osteoclast and, if so, by what means, is unclear. We find that whereas deletion of Rac1 or Rac2 alone has no effect, variable reduction of Rac1 in osteoclastic cells of Rac2(-/-) mice causes severe osteopetrosis. Osteoclasts lacking Rac1 and Rac2 in combination (Rac double-knockout, RacDKO), fail to effectively resorb bone. By contrast, osteoclasts are abundant in RacDKO osteopetrotic mice and, unlike those deficient in Cdc42, express the maturation markers of the cells normally. Hence, the osteopetrotic lesion of RacDKO mice largely reflects impaired function, and not arrested differentiation, of the resorptive polykaryon. The dysfunction of RacDKO osteoclasts represents failed cytoskeleton organization as evidenced by reduced motility of the cells and their inability to spread or generate the key resorptive organelles (i.e. actin rings and ruffled borders), which is accompanied by abnormal Arp3 distribution. The cytoskeleton-organizing capacity of Rac1 is mediated through its 20-amino-acid effector domain. Thus, Rac1 and Rac2 are mutually compensatory. Unlike Cdc42 deficiency, their combined absence does not impact upon differentiation but promotes severe osteopetrosis by dysregulating the osteoclast cytoskeleton.
- Published
- 2011
- Full Text
- View/download PDF
29. Disruption of the Man-6-P targeting pathway in mice impairs osteoclast secretory lysosome biogenesis.
- Author
-
van Meel E, Boonen M, Zhao H, Oorschot V, Ross FP, Kornfeld S, and Klumperman J
- Subjects
- Acid Phosphatase metabolism, Animals, Cathepsin D metabolism, Cathepsin K metabolism, Cell Differentiation physiology, Cells, Cultured, Endosomes metabolism, Endosomes ultrastructure, Isoenzymes metabolism, Lysosomes ultrastructure, Macrophages cytology, Macrophages physiology, Mice, Mice, Knockout, Microscopy, Immunoelectron, Signal Transduction physiology, Tartrate-Resistant Acid Phosphatase, Transferases (Other Substituted Phosphate Groups) genetics, Transferases (Other Substituted Phosphate Groups) metabolism, trans-Golgi Network metabolism, trans-Golgi Network ultrastructure, Lysosomes metabolism, Mannosephosphates metabolism, Osteoclasts metabolism, Osteoclasts ultrastructure
- Abstract
Osteoclasts are specialized cells that secrete lysosomal acid hydrolases at the site of bone resorption, a process critical for skeletal formation and remodeling. However, the cellular mechanism underlying this secretion and the organization of the endo-lysosomal system of osteoclasts have remained unclear. We report that osteoclasts differentiated in vitro from murine bone marrow macrophages contain two types of lysosomes. The major species is a secretory lysosome containing cathepsin K and tartrate-resistant acid phosphatase (TRAP), two hydrolases critical for bone resorption. These secretory lysosomes are shown to fuse with the plasma membrane, allowing the regulated release of acid hydrolases at the site of bone resorption. The other type of lysosome contains cathepsin D, but little cathepsin K or TRAP. Osteoclasts from Gnptab(-/-) (gene encoding GlcNAc-1-phosphotransferase α, β-subunits) mice, which lack a functional mannose 6-phosphate (Man-6-P) targeting pathway, show increased secretion of cathepsin K and TRAP and impaired secretory lysosome formation. However, cathepsin D targeting was intact, showing that osteoclasts have a Man-6-P-independent pathway for selected acid hydrolases., (© 2011 John Wiley & Sons A/S.)
- Published
- 2011
- Full Text
- View/download PDF
30. Calpain-6, a target molecule of glucocorticoids, regulates osteoclastic bone resorption via cytoskeletal organization and microtubule acetylation.
- Author
-
Hong JM, Teitelbaum SL, Kim TH, Ross FP, Kim SY, and Kim HJ
- Subjects
- Acetylation drug effects, Animals, Calpain genetics, Cell Movement drug effects, Cytoskeleton drug effects, Dexamethasone pharmacology, Gene Knockdown Techniques, Integrin beta3 genetics, Integrin beta3 metabolism, Mice, Mice, Inbred C57BL, Microtubules drug effects, Osteoclasts enzymology, Osteogenesis drug effects, Osteogenesis genetics, Up-Regulation drug effects, Bone Resorption enzymology, Bone Resorption pathology, Calpain metabolism, Cytoskeleton metabolism, Glucocorticoids pharmacology, Microtubules metabolism, Osteoclasts pathology
- Abstract
Glucocorticoids (GCs) inhibit the resorptive capacity of the osteoclast by disrupting its cytoskeleton. We find that calpain-6 (Capn6), a unique, nonproteolytic member of its family, is suppressed 12-fold by dexamethasone (DEX) in the bone-degrading cell. While Capn6 abundance parallels commitment of naive bone marrow macrophages (BMMs) to the osteoclast phenotype, its excess or deletion does not affect the cell's differentiation. On the other hand, Capn6 localizes to the sealing zone, and its overexpression promotes osteoclast spreading and large actin ring formation, eventuating in stimulated bone degradation. Conversely, Capn6 knockdown impairs cytoskeletal organization and the cell's resorptive capacity. Capn6 complexes with tubulin, and its absence inhibits microtubule acetylation and stability in the osteoclast. Knockdown of Capn6 also reduces β(3)-integrin subunit protein, another essential regulator of osteoclast cytoskeletal function. Reflecting Capn6 as a target molecule of GCs, microtubule stability and acetylation, as well as the expression of β(3)-integrin protein, are similarly suppressed in DEX-treated osteoclasts. Moreover, overexpression of Capn6 rescues GC-mediated disruption of osteoclast cytoskeleton. Thus Capn6 promotes cytoskeletal organization and microtubule stability in osteoclasts, and its inhibition may mediate the resorption-arresting properties of GCs., (Copyright © 2011 American Society for Bone and Mineral Research.)
- Published
- 2011
- Full Text
- View/download PDF
31. Fyn promotes proliferation, differentiation, survival and function of osteoclast lineage cells.
- Author
-
Kim HJ, Warren JT, Kim SY, Chappel JC, DeSelm CJ, Ross FP, Zou W, and Teitelbaum SL
- Subjects
- Animals, Apoptosis, Bone Resorption, Cell Lineage, Cell Survival, Mice, Proto-Oncogene Proteins c-fyn deficiency, RANK Ligand physiology, Cell Differentiation, Cell Proliferation, Osteoclasts cytology, Proto-Oncogene Proteins c-fyn physiology
- Abstract
c-Src and Lyn are the only Src family kinases (SFKs) with established activity in osteoclasts (OCs). c-Src promotes function via cytoskeletal organization of the mature resorptive cell while Lyn is a negative regulator of osteoclastogenesis. We establish that Fyn, another SFK, also impacts the OC, but in a manner distinctly different than c-Src and Lyn. Fyn deficiency principally alters cells throughout the osteoclastogenic process, resulting in diminished numbers of resorptive polykaryons. Arrested OC formation in the face of insufficient Fyn reflects reduced proliferation of precursors, in response to M-CSF and retarded RANK ligand (RANKL)-induced differentiation, attended by suppressed activation of the osteoclastogenic signaling molecules, c-Jun, and NF-κB. The anti-apoptotic properties of RANKL are also compromised in cells deleted of Fyn, an event mediated by increased Bim expression and failed activation of Akt. The defective osteoclastogenesis of Fyn-/- OCs dampens bone resorption, in vitro. Finally, while Fyn deficiency does not regulate basal osteoclastogenesis, in vivo, it reduces that stimulated by RANKL by ~2/3. Thus, Fyn is a pro-resorptive SFK, which exerts its effects by prompting proliferation and differentiation while attenuating apoptosis of OC lineage cells., (Copyright © 2010 Wiley-Liss, Inc.)
- Published
- 2010
- Full Text
- View/download PDF
32. Bone loss caused by iron overload in a murine model: importance of oxidative stress.
- Author
-
Tsay J, Yang Z, Ross FP, Cunningham-Rundles S, Lin H, Coleman R, Mayer-Kuckuk P, Doty SB, Grady RW, Giardina PJ, Boskey AL, and Vogiatzi MG
- Subjects
- Acetylcysteine therapeutic use, Animals, Antioxidants therapeutic use, Bone and Bones drug effects, Bone and Bones metabolism, Bone and Bones pathology, Iron Overload chemically induced, Iron Overload metabolism, Iron-Dextran Complex, Male, Mice, Mice, Inbred C57BL, Osteoporosis drug therapy, Osteoporosis metabolism, Osteoporosis pathology, Iron Overload complications, Osteoporosis etiology, Oxidative Stress
- Abstract
Osteoporosis is a frequent problem in disorders characterized by iron overload, such as the thalassemias and hereditary hemochromatosis. The exact role of iron in the development of osteoporosis in these disorders is not established. To define the effect of iron excess in bone, we generated an iron-overloaded mouse by injecting iron dextran at 2 doses into C57/BL6 mice for 2 months. Compared with the placebo group, iron-overloaded mice exhibited dose-dependent increased tissue iron content, changes in bone composition, and trabecular and cortical thinning of bone accompanied by increased bone resorption. Iron-overloaded mice had increased reactive oxygen species and elevated serum tumor necrosis factor-α and interleukin-6 concentrations that correlated with severity of iron overload. Treatment of iron-overloaded mice with the antioxidant N-acetyl-L-cysteine prevented the development of trabecular but not cortical bone abnormalities. This is the first study to demonstrate that iron overload in mice results in increased bone resorption and oxidative stress, leading to changes in bone microarchitecture and material properties and thus bone loss.
- Published
- 2010
- Full Text
- View/download PDF
33. The relative timing of exposure to phagocytosable particulates and to osteoclastogenic cytokines is critically important in the determination of myeloid cell fate.
- Author
-
James DE, Nestor BJ, Sculco TP, Ivashkiv LB, Ross FP, Goldring SR, and Purdue PE
- Subjects
- Cathepsin K genetics, Cathepsin K metabolism, Cell Differentiation drug effects, Cells, Cultured, Dose-Response Relationship, Drug, Gene Expression drug effects, Humans, Immunoblotting, Macrophage Colony-Stimulating Factor pharmacology, Monocytes cytology, Monocytes metabolism, Myeloid Cells cytology, Myeloid Cells metabolism, Osteoclasts cytology, Osteoclasts drug effects, Particulate Matter metabolism, Phagocytosis, Polymethyl Methacrylate metabolism, Polymethyl Methacrylate pharmacology, RANK Ligand pharmacology, Receptor Activator of Nuclear Factor-kappa B genetics, Receptor Activator of Nuclear Factor-kappa B metabolism, Receptor, Macrophage Colony-Stimulating Factor genetics, Receptor, Macrophage Colony-Stimulating Factor metabolism, Reverse Transcriptase Polymerase Chain Reaction, Silicon Dioxide metabolism, Silicon Dioxide pharmacology, Time Factors, Titanium metabolism, Titanium pharmacology, Cytokines pharmacology, Monocytes drug effects, Myeloid Cells drug effects, Particulate Matter pharmacology
- Abstract
During granulomatous inflammatory reactions, myeloid cells can differentiate into activated phagocytic macrophages, wound-healing macrophages, foreign body giant cells, and bone-resorbing osteoclasts. Although it is appreciated that a variety of stimuli, including cytokines, cell-matrix interactions, and challenge with foreign materials can influence myeloid cell fate, little is known of how these signals integrate during this process. In this study, we have investigated the cross talk between receptor activator of NF-kappaB ligand (RANKL)-induced osteoclastogenesis and particle phagocytosis-induced activation of human monocytes. Understanding interconnected signals is of particular importance to disorders, such as periprosthetic osteolysis, in which granulomatous inflammation is initiated by particle phagocytosis in proximity to bone and leads to inflammatory bone loss. Using cell-based osteoclastogenesis and phagocytosis assays together with expression analysis of key regulators of osteoclastogenesis, we show in this study that phagocytosis of disease-relevant particles inhibits RANKL-mediated osteoclastogenesis of human monocytes. Mechanistically, phagocytosis mediates this effect by downregulation of RANK and c-Fms, the receptors for the essential osteoclastogenic cytokines RANKL and M-CSF. RANKL pretreatment of monocytes generates preosteoclasts that are resistant to RANK downregulation and committed to osteoclast formation, even though they retain phagocytic activity. Thus, the relative timing of exposure to phagocytosable particulates and to osteoclastogenic cytokines is critically important in the determination of myeloid cell fate.
- Published
- 2010
- Full Text
- View/download PDF
34. Osteoclast-specific inactivation of the integrin-linked kinase (ILK) inhibits bone resorption.
- Author
-
Dossa T, Arabian A, Windle JJ, Dedhar S, Teitelbaum SL, Ross FP, Roodman GD, and St-Arnaud R
- Subjects
- Acid Phosphatase genetics, Animals, Isoenzymes genetics, Mice, Mice, Transgenic, Reverse Transcriptase Polymerase Chain Reaction, Tartrate-Resistant Acid Phosphatase, Tomography, Bone Resorption, Osteoclasts physiology, Protein Serine-Threonine Kinases antagonists & inhibitors
- Abstract
Bone resorption requires the adhesion of osteoclasts to extracellular matrix (ECM) components, a process mediated by the alpha(v)beta(3) integrin. Following engagement with the ECM, integrin receptors signal via multiple downstream effectors, including the integrin-linked kinase (ILK). In order to characterize the physiological role of ILK in bone resorption, we generated mice with an osteoclast-specific Ilk gene ablation by mating mice with a floxed Ilk allele with TRAP-Cre transgenic mice. The TRAP-Cre mice specifically excised floxed alleles in osteoclasts, as revealed by crossing them with the ROSA26R reporter strain. Osteoclast-specific Ilk mutant mice appeared phenotypically normal, but histomorphometric analysis of the proximal tibia revealed an increase in bone volume and trabecular thickness. Osteoclast-specific Ilk ablation was associated with an increase in osteoclastogenesis both in vitro and in vivo. However, the mutant osteoclasts displayed a decrease in resorption activity as assessed by reduced pit formation on dentin slices in vitro and decreased serum concentrations of the C-terminal telopeptide of collagen in vivo. Interestingly, compound heterozygous mice in which one allele of Ilk and one allele of the beta(3) integrin gene were inactivated (ILK(+/-); beta(3) (+/-)) also had increased trabecular thickness, confirming that beta(3) integrin and Ilk form part of the same genetic cascade. Our results show that ILK is important for the function, but not the differentiation, of osteoclasts., (J. Cell. Biochem. 110: 960-967, 2010. (c) 2010 Wiley-Liss, Inc.)
- Published
- 2010
- Full Text
- View/download PDF
35. Cdc42 regulates bone modeling and remodeling in mice by modulating RANKL/M-CSF signaling and osteoclast polarization.
- Author
-
Ito Y, Teitelbaum SL, Zou W, Zheng Y, Johnson JF, Chappel J, Ross FP, and Zhao H
- Subjects
- Animals, Apoptosis drug effects, Apoptosis physiology, Bone Resorption metabolism, Caspase 3 metabolism, Cell Differentiation drug effects, Cyclin D1 metabolism, Cytoskeleton metabolism, Female, Macrophage Colony-Stimulating Factor biosynthesis, Macrophage Colony-Stimulating Factor metabolism, Mice, Mice, Knockout, Osteoclasts cytology, Osteoclasts metabolism, Phosphorylation, Bone and Bones metabolism, Macrophage Colony-Stimulating Factor pharmacology, Osteoclasts physiology, RANK Ligand metabolism, Signal Transduction drug effects
- Abstract
The modeling and remodeling of bone requires activation and polarization of osteoclasts, achieved by reorganization of the cytoskeleton. Members of the Rho subfamily of small GTPases, including Cdc42, are known regulators of cytoskeletal components, but the role of these proteins in bone physiology and pathophysiology remains unclear. Here, we examined loss-of-function mice in which Cdc42 was selectively ablated in differentiated osteoclasts and gain-of-function animals wherein Cdc42Gap, a protein that inactivates the small GTPase, was deleted globally. Cdc42 loss-of-function mice were osteopetrotic and resistant to ovariectomy-induced bone loss, while gain-of-function animals were osteoporotic. Isolated Cdc42-deficient osteoclasts displayed suppressed bone resorption, while osteoclasts with increased Cdc42 activity had enhanced resorptive capacity. We further demonstrated that Cdc42 modulated M-CSF-stimulated cyclin D expression and phosphorylation of Rb and induced caspase 3 and Bim, thus contributing to osteoclast proliferation and apoptosis rates. Furthermore, Cdc42 was required for multiple M-CSF- and RANKL-induced osteoclastogenic signals including activation and expression of the differentiation factors MITF and NFATc1 and was a component of the Par3/Par6/atypical PKC polarization complex in osteoclasts. These data suggest that Cdc42 regulates osteoclast formation and function and may represent a promising therapeutic target for prevention of pathological bone loss.
- Published
- 2010
- Full Text
- View/download PDF
36. Src-like adaptor protein regulates osteoclast generation and survival.
- Author
-
Kim HJ, Zou W, Ito Y, Kim SY, Chappel J, Ross FP, and Teitelbaum SL
- Subjects
- Animals, Apoptosis drug effects, Biomarkers metabolism, Cell Count, Cell Proliferation drug effects, Cell Survival drug effects, Enzyme Activation drug effects, Extracellular Signal-Regulated MAP Kinases metabolism, Macrophage Colony-Stimulating Factor pharmacology, Membrane Microdomains drug effects, Membrane Microdomains metabolism, Mice, Osteoclasts drug effects, Osteoclasts enzymology, Osteogenesis drug effects, Phosphorylation drug effects, Proto-Oncogene Proteins pp60(c-src) deficiency, Receptor, Macrophage Colony-Stimulating Factor metabolism, Stem Cells cytology, Stem Cells drug effects, Stem Cells metabolism, Osteoclasts cytology, Osteoclasts metabolism, Proto-Oncogene Proteins pp60(c-src) metabolism
- Abstract
Src-like adaptor protein (SLAP) is a hematopoietic adaptor containing Src homology (SH)3 and SH2 motifs and a unique carboxy terminus. Unlike c-Src, SLAP lacks a tyrosine kinase domain. We investigated the role of SLAP in osteoclast development and resorptive function. Employing SLAP-deficient mice, we find lack of the adaptor enhances in vitro proliferation of osteoclast precursors in the form of bone marrow macrophages (BMMs), without altering their survival. Furthermore, osteoclastogenic markers appear more rapidly in SLAP-/- BMMs exposed to RANK ligand (RANKL). The accelerated proliferation of M-CSF-treated, SLAP-deficient precursors is associated with enhanced ERK activation. SLAP's role as a mediator of M-CSF signaling, in osteoclastic cells, is buttressed by complexing of the adaptor protein and c-Fms in lipid rafts. Unlike c-Src, SLAP does not impact resorptive function of mature osteoclasts but induces their early apoptosis. Thus, SLAP negatively regulates differentiation of osteoclasts and proliferation of their precursors. Conversely, SLAP decreases osteoclast death by inhibiting activation of caspase 3. These counterbalancing events yield indistinguishable bones of WT and SLAP-/- mice which contain equal numbers of osteoclasts in basal and stimulated conditions., ((c) 2010 Wiley-Liss, Inc.)
- Published
- 2010
- Full Text
- View/download PDF
37. Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit.
- Author
-
Morgan EA, Schneider JG, Baroni TE, Uluçkan O, Heller E, Hurchla MA, Deng H, Floyd D, Berdy A, Prior JL, Piwnica-Worms D, Teitelbaum SL, Ross FP, and Weilbaecher KN
- Subjects
- Animals, Blood Platelets pathology, Bone Resorption genetics, Bone Resorption pathology, Cell Line, Tumor, Hemorrhage genetics, Hemorrhage metabolism, Hemorrhage pathology, Humans, Integrin beta3 genetics, Macrophages pathology, Melanoma genetics, Melanoma pathology, Mice, Mice, Knockout, Neoplasm Transplantation, Organ Specificity genetics, Transplantation, Heterologous, Blood Platelets metabolism, Bone Resorption metabolism, Hemostasis, Integrin beta3 metabolism, Macrophages metabolism, Melanoma metabolism
- Abstract
The purpose of this work was to determine platelet and myeloid cell-specific requirements for beta3-containing integrins in hemostasis, bone resorption, and tumor growth. LoxP-flanked mice were generated to study the conditional deletion of beta3-integrin in platelets [knockout in platelets (KOP)] and myeloid cells [knockout in myeloid (KOM)]. Using the beta3KOP and beta3KOM strains of mice, we studied the role of beta3-integrin in hemostasis, bone resorption, and subcutaneous tumor growth. Tissue-specific deletion of platelet beta3-integrins in beta3KOP mice did not affect bone mass but resulted in a severe bleeding phenotype. No growth difference of tumor xenografts or in neoangiogenesis were found in beta3KOP mice, in contrast to the defects observed in germline beta3(-/-) mice. Conditional deletion of myeloid beta3-integrins in beta3KOM mice resulted in osteopetrosis but had no effect on hemostasis or mortality. Tumor growth in beta3KOM mice was increased and accompanied by decreased macrophage infiltration, without increase in blood vessel number. Platelet beta3-integrin deficiency was sufficient to disrupt hemostasis but had no effect on bone mass or tumor growth. Myeloid-specific beta3-integrin deletion was sufficient to perturb bone mass and enhance tumor growth due to reduced macrophage infiltration in the tumors. These results suggest that beta3-integrins have cell-specific roles in complex biological processes.-Morgan, E. A., Schneider, J. G., Baroni, T. E., Uluçkan, O., Heller, E., Hurchla, M. A., Deng, H., Floyd, D., Berdy, A., Prior, J. L., Piwnica-Worms, D., Teitelbaum, S. L., Ross, F. P., Weilbaecher, K. N. Dissection of platelet and myeloid cell defects by conditional targeting of the beta3-integrin subunit.
- Published
- 2010
- Full Text
- View/download PDF
38. How do bone cells secrete proteins?
- Author
-
Zhao H, Ito Y, Chappel J, Andrews N, Ross FP, and Teitelbaum SL
- Subjects
- Animals, Bone Resorption pathology, Mice, Models, Biological, Osteogenesis, Synaptotagmins metabolism, Osteoclasts metabolism
- Abstract
The ruffled border is the most specific marker of the active osteoclast (OC) as it forms only when the cell is resorbing bone. We provide evidence that this complex cytoskeletal structure reflects insertion of the lysosomal vesicles into the bone-apposed plasma membrane under the aegis of the Ca-sensing, exocytic protein, synaptotagmin VII (SytVII). In the manner, SytVII permits transport of matrix-degrading molecules into the resorptive microenvironment. SytVII also regulates secretion of bone matrix molecules by osteoblasts. Thus, SytVII-deficient mice experience suppressed bone resorption and formation with the latter deficiency predominant thereby yielding osteoporosis characterized by attenuated remodeling.
- Published
- 2010
- Full Text
- View/download PDF
39. SLP-76 couples Syk to the osteoclast cytoskeleton.
- Author
-
Reeve JL, Zou W, Liu Y, Maltzman JS, Ross FP, and Teitelbaum SL
- Subjects
- Adaptor Proteins, Signal Transducing physiology, Animals, Binding Sites, Bone Resorption, Mice, Mice, Knockout, Osteoclasts ultrastructure, Phosphoproteins physiology, Phosphorylation, Protein Binding, Proto-Oncogene Proteins c-vav physiology, Syk Kinase, Adaptor Proteins, Signal Transducing metabolism, Cytoskeleton metabolism, Intracellular Signaling Peptides and Proteins metabolism, Osteoclasts physiology, Phosphoproteins metabolism, Protein-Tyrosine Kinases metabolism, Proto-Oncogene Proteins c-vav metabolism
- Abstract
The capacity of the osteoclast (OC) to resorb bone is dictated by cytoskeletal organization, which in turn emanates from signals derived from the alpha(v)beta(3) integrin and c-Fms. Syk is key to these signals and, in other cells, this tyrosine kinase exerts its effects via intermediaries including the SLP adaptors, SLP-76 and BLNK (B cell linker). Thus, we asked whether these two SLP proteins regulate OC function. We find BLNK-deficient OCs are normal, whereas cytoskeletal organization of those lacking SLP-76 is delayed, thus modestly reducing bone resorption in vitro. Cytoskeletal organization and bone resorption are more profoundly arrested in cultured OCs deficient in BLNK and SLP-76 double knockout (DKO) phenotypes. In contrast, stimulated bone resorption in vivo is inhibited approximately 40% in either SLP-76(-/-) or DKO mice. This observation, taken with the fact that DKO OCs are rescued by retroviral transduction of only SLP-76, indicates that SLP-76 is the dominant SLP family member in the resorptive process. We also find SLP-76 is phosphorylated in a Syk-dependent manner. Furthermore, in the absence of the adaptor protein, integrin-mediated phosphorylation of Vav3, the OC cytoskeleton-organizing guanine nucleotide exchange factor, is abrogated. In keeping with a central role of SLP-76/Vav3 association in osteoclastic resorption, retroviral transduction of SLP-76, in which the Vav binding site is disrupted (3YF), fails to normalize the cytoskeleton of DKO OCs and the resorptive capacity of the cells. Finally, c-Fms-activated Syk also exerts its OC cytoskeleton-organizing effect in a SLP-76/Vav3-dependent manner.
- Published
- 2009
- Full Text
- View/download PDF
40. Syk tyrosine 317 negatively regulates osteoclast function via the ubiquitin-protein isopeptide ligase activity of Cbl.
- Author
-
Zou W, Reeve JL, Zhao H, Ross FP, and Teitelbaum SL
- Subjects
- Animals, Cell Differentiation, Cells, Cultured, Homeostasis, Integrins metabolism, Intracellular Signaling Peptides and Proteins metabolism, Macrophage Colony-Stimulating Factor metabolism, Mice, Mice, Transgenic, Models, Biological, Phosphorylation, Protein-Tyrosine Kinases metabolism, Syk Kinase, Intracellular Signaling Peptides and Proteins physiology, Osteoclasts metabolism, Peptide Synthases metabolism, Protein-Tyrosine Kinases physiology, Proto-Oncogene Proteins c-cbl metabolism, Tyrosine chemistry, Ubiquitin chemistry
- Abstract
Cytoskeletal organization of the osteoclast (OC), which is central to the capacity of the cell to resorb bone, is induced by occupancy of the alphavbeta3 integrin or the macrophage colony-stimulating factor (M-CSF) receptor c-Fms. In both circumstances, the tyrosine kinase Syk is an essential signaling intermediary. We demonstrate that Cbl negatively regulates OC function by interacting with Syk(Y317). Expression of nonphosphorylatable Syk(Y317F) in primary Syk(-/-) OCs enhances M-CSF- and alphavbeta3-induced phosphorylation of the cytoskeleton-organizing molecules, SLP76, Vav3, and PLCgamma2, to levels greater than wild type, thereby accelerating the resorptive capacity of the cell. Syk(Y317) suppresses cytoskeletal organization and function while binding the ubiquitin-protein isopeptide ligase Cbl. Consequently, Syk(Y317F) abolishes M-CSF- and integrin-stimulated Syk ubiquitination. Thus, Cbl/Syk(Y317) association negatively regulates OC function and therefore is essential for maintenance of skeletal homeostasis.
- Published
- 2009
- Full Text
- View/download PDF
41. The Src family kinase, Lyn, suppresses osteoclastogenesis in vitro and in vivo.
- Author
-
Kim HJ, Zhang K, Zhang L, Ross FP, Teitelbaum SL, and Faccio R
- Subjects
- Adaptor Proteins, Signal Transducing, Animals, Bone Resorption, In Vitro Techniques, Macrophage Colony-Stimulating Factor metabolism, Mice, Mice, Inbred C57BL, Mutation, NF-kappa B metabolism, Phosphoproteins metabolism, Phosphorylation, Protein Tyrosine Phosphatase, Non-Receptor Type 6 metabolism, RANK Ligand metabolism, Signal Transduction, src-Family Kinases metabolism, Osteoclasts metabolism, src-Family Kinases physiology
- Abstract
c-Src kinase is a rate-limiting activator of osteoclast (OC) function and Src inhibitors are therefore candidate antiosteoporosis drugs. By affecting alphavbeta3 and macrophage-colony stimulating factor (M-CSF)-induced signaling, c-Src is central to osteoclast activity, but not differentiation. We find Lyn, another member of Src family kinases (SFK) is, in contrast, a negative regulator of osteoclastic bone resorption. The absence of Lyn enhances receptor activator of NF-kappaB ligand (RANKL)-mediated differentiation of osteoclast precursors without affecting proliferation and survival, while its overexpression decreases osteoclast formation. In further contrast to c-Src, Lyn deficiency does not impact the activity of the mature cell. Reflecting increased osteoclast development in vitro, Lyn-/- mice undergo accelerated osteoclastogenesis and bone loss, in vivo, in response to RANKL. Mechanistically, Lyn forms a complex with receptor activator of NF-kappaB (RANK), the tyrosine phosphatase, SHP-1, and the adapter protein, Grb2-associated binder 2 (Gab2). Upon RANKL exposure, Gab2 phosphorylation, JNK, and NF-kappaB activation are enhanced in Lyn-/- osteoclasts, all critical events in osteoclast development. We therefore establish that Lyn regulates osteoclast formation and does it in a manner antithetical to that of c-Src. The most pragmatic aspect of our findings is that successful therapeutic inhibition of c-Src, in the context of the osteoclast, will require its stringent targeting.
- Published
- 2009
- Full Text
- View/download PDF
42. Tumor necrosis factor receptor-associated factor 6 is an intranuclear transcriptional coactivator in osteoclasts.
- Author
-
Bai S, Zha J, Zhao H, Ross FP, and Teitelbaum SL
- Subjects
- Animals, COS Cells, Cell Nucleus genetics, Cell Nucleus metabolism, Chlorocebus aethiops, Core Binding Factor Alpha 2 Subunit genetics, Cytoplasm genetics, Cytoplasm metabolism, Homeodomain Proteins genetics, Humans, LIM-Homeodomain Proteins, Mice, Monocyte-Macrophage Precursor Cells cytology, Monocyte-Macrophage Precursor Cells metabolism, Multiprotein Complexes genetics, Muscle Proteins genetics, Osteoclasts cytology, Proteasome Endopeptidase Complex genetics, Proteasome Endopeptidase Complex metabolism, RANK Ligand genetics, RANK Ligand metabolism, Receptor Activator of Nuclear Factor-kappa B genetics, Receptor Activator of Nuclear Factor-kappa B metabolism, Response Elements physiology, Signal Transduction physiology, TNF Receptor-Associated Factor 6 genetics, Transcription Factors genetics, Ubiquitination physiology, Core Binding Factor Alpha 2 Subunit metabolism, Gene Expression Regulation physiology, Homeodomain Proteins metabolism, Multiprotein Complexes metabolism, Muscle Proteins metabolism, Osteoclasts metabolism, TNF Receptor-Associated Factor 6 metabolism, Transcription Factors metabolism, Transcription, Genetic physiology
- Abstract
Tumor necrosis factor receptor-associated factor 6 (TRAF6) associates with the cytoplasmic domain of receptor activator of NF-kappaB (RANK) and is an essential component of the signaling complex mediating osteoclastogenesis. However, the osteoclastic activity of TRAF6 is blunted by its association with four and half LIM domain 2 (FHL2), which functions as an adaptor protein in the cytoplasm and transcriptional regulator in the nucleus. We find that TRAF6 also localizes in the nuclei of osteoclasts but not their bone marrow macrophage precursors and that osteoclast intranuclear abundance is specifically increased by RANK ligand (RANKL). TRAF6 nuclear localization requires FHL2 and is diminished in fhl2(-/-) osteoclasts. Suggesting transcriptional activity, TRAF6 interacts with the transcription factor RUNX1 in the osteoclast nucleus. FHL2 also associates with RUNX1 but does so only in the presence of TRAF6. Importantly, TRAF6 recognizes FHL2 and RUNX1 in osteoclast nuclei, and the three molecules form a DNA-binding complex that recognizes and transactivates the RUNX1 response element in the fhl2 promoter. Finally, TRAF6 and its proximal activator, RANKL, polyubiquitinate FHL2, prompting its proteasomal degradation. These observations suggest a feedback mechanism whereby TRAF6 negatively regulates osteoclast formation by intracytoplasmic sequestration of FHL2 to blunt RANK activation and as a component of a transcription complex promoting FHL2 expression.
- Published
- 2008
- Full Text
- View/download PDF
43. DAP12 couples c-Fms activation to the osteoclast cytoskeleton by recruitment of Syk.
- Author
-
Zou W, Reeve JL, Liu Y, Teitelbaum SL, and Ross FP
- Subjects
- Actins metabolism, Adaptor Proteins, Signal Transducing chemistry, Adaptor Proteins, Signal Transducing deficiency, Amino Acid Motifs, Animals, Cytoskeleton drug effects, Enzyme Activation drug effects, Intracellular Signaling Peptides and Proteins chemistry, Macrophage Colony-Stimulating Factor pharmacology, Mice, Osteoclasts drug effects, Phosphorylation drug effects, Protein-Tyrosine Kinases chemistry, Proto-Oncogene Proteins pp60(c-src) metabolism, Signal Transduction drug effects, Syk Kinase, src Homology Domains, Adaptor Proteins, Signal Transducing metabolism, Cytoskeleton enzymology, Intracellular Signaling Peptides and Proteins metabolism, Osteoclasts cytology, Osteoclasts enzymology, Protein-Tyrosine Kinases metabolism, Receptor, Macrophage Colony-Stimulating Factor metabolism
- Abstract
We examined the mechanism by which M-CSF regulates the cytoskeleton and function of the osteoclast, the exclusive bone resorptive cell. We show that binding of M-CSF to its receptor c-Fms generates a signaling complex comprising phosphorylated DAP12, an adaptor containing an immunoreceptor tyrosine-based activation motif (ITAM) and the nonreceptor tyrosine kinase Syk. c-Fms tyrosine 559, the exclusive binding site of c-Src, is necessary for regulation of DAP12/Syk signaling. Deletion of either of these molecules yields osteoclasts that fail to reorganize their cytoskeleton. Retroviral transduction of null precursors with wild-type or mutant DAP12 or Syk reveals that the SH2 domain of Syk and the ITAM tyrosine residues and transmembrane domain of DAP12 mediate M-CSF signaling. Our data provide genetic and biochemical evidence that uncovers an epistatic signaling pathway linking the receptor tyrosine kinase c-Fms to the immune adaptor DAP12 and the cytoskeleton.
- Published
- 2008
- Full Text
- View/download PDF
44. Synaptotagmin VII regulates bone remodeling by modulating osteoclast and osteoblast secretion.
- Author
-
Zhao H, Ito Y, Chappel J, Andrews NW, Teitelbaum SL, and Ross FP
- Subjects
- Animals, Cell Differentiation, Cells, Cultured, Collagen Type I metabolism, Exocytosis, Green Fluorescent Proteins metabolism, Lysosomes metabolism, Mice, Mice, Knockout, Osteoblasts ultrastructure, Osteocalcin metabolism, Osteoclasts ultrastructure, Osteopontin metabolism, Retroviridae genetics, Skull cytology, Synaptotagmins genetics, Transduction, Genetic, Bone Remodeling, Osteoblasts metabolism, Osteoclasts metabolism, Synaptotagmins deficiency, Synaptotagmins physiology
- Abstract
Maintenance of bone mass and integrity requires a tight balance between resorption by osteoclasts and formation by osteoblasts. Exocytosis of functional proteins is a prerequisite for the activity of both cells. In the present study, we show that synaptotagmin VII, a calcium sensor protein that regulates exocytosis, is associated with lysosomes in osteoclasts and bone matrix protein-containing vesicles in osteoblasts. Absence of synaptotagmin VII inhibits cathepsin K secretion and formation of the ruffled border in osteoclasts and bone matrix protein deposition in osteoblasts, without affecting the differentiation of either cell. Reflecting these in vitro findings, synaptotagmin VII-deficient mice are osteopenic due to impaired bone resorption and formation. Therefore, synaptotagmin VII plays an important role in bone remodeling and homeostasis by modulating secretory pathways functionally important in osteoclasts and osteoblasts.
- Published
- 2008
- Full Text
- View/download PDF
45. NOTCH1 regulates osteoclastogenesis directly in osteoclast precursors and indirectly via osteoblast lineage cells.
- Author
-
Bai S, Kopan R, Zou W, Hilton MJ, Ong CT, Long F, Ross FP, and Teitelbaum SL
- Subjects
- Animals, Bone Marrow Cells pathology, Bone Resorption genetics, Bone Resorption pathology, Cells, Cultured, Female, Macrophage Colony-Stimulating Factor pharmacology, Male, Mice, Osteoblasts pathology, Osteoclasts pathology, RANK Ligand pharmacology, Receptor, Notch1 genetics, Receptor, Notch2 genetics, Receptor, Notch2 metabolism, Receptor, Notch3, Receptors, Notch genetics, Receptors, Notch metabolism, Signal Transduction drug effects, Signal Transduction genetics, Bone Marrow Cells metabolism, Bone Resorption metabolism, Cell Differentiation drug effects, Cell Differentiation genetics, Osteoblasts metabolism, Osteoclasts metabolism, Receptor, Notch1 metabolism
- Abstract
NOTCH signaling is a key regulator of cell fate decisions in prenatal skeletal development and is active during adult tissue renewal. In addition, its association with neoplasia suggests that it is a candidate therapeutic target. We find that attenuated NOTCH signaling enhances osteoclastogenesis and bone resorption in vitro and in vivo by a combination of molecular mechanisms. First, deletion of Notch1-3 in bone marrow macrophages directly promotes their commitment to the osteoclast phenotype. These osteoclast precursors proliferate more rapidly than the wild type in response to macrophage colony-stimulating factor and are sensitized to RANKL and macrophage colony-stimulating factor, undergoing enhanced differentiation in response to low doses of either cytokine. Conforming with a role for NOTCH in this process, presentation of the NOTCH ligand JAGGED1 blunts the capacity of wild-type bone marrow macrophages to become osteoclasts. Combined, these data establish that NOTCH suppresses osteoclastogenesis via ligand-mediated receptor activation. Although NOTCH1 and NOTCH3 collaborate in regulating osteoclast formation, NOTCH1 is the dominant paralog. In addition, NOTCH1 deficiency promotes osteoclastogenesis indirectly by enhancing the ability of osteoblast lineage cells to stimulate osteoclastogenesis. This is achieved by decreasing the osteoprotegerin/RANKL expression ratio. Thus, NOTCH1 acts as a net inhibitor of bone resorption, exerting its effect both directly in osteoclast precursors and indirectly via osteoblast lineage cells. These observations raise caution that therapeutic inhibition of NOTCH signaling may adversely accelerate bone loss in humans.
- Published
- 2008
- Full Text
- View/download PDF
46. Notch signaling maintains bone marrow mesenchymal progenitors by suppressing osteoblast differentiation.
- Author
-
Hilton MJ, Tu X, Wu X, Bai S, Zhao H, Kobayashi T, Kronenberg HM, Teitelbaum SL, Ross FP, Kopan R, and Long F
- Subjects
- Aging, Amyloid Precursor Protein Secretases genetics, Amyloid Precursor Protein Secretases metabolism, Animals, Bone Development genetics, Bone Development physiology, Bone Marrow Cells metabolism, Cells, Cultured, Embryo, Mammalian cytology, Embryo, Mammalian embryology, Embryo, Mammalian metabolism, Gene Deletion, Mesenchymal Stem Cells metabolism, Mice, Mutation, Phenotype, Receptors, Notch deficiency, Receptors, Notch genetics, Bone Marrow Cells cytology, Cell Differentiation, Mesenchymal Stem Cells cytology, Osteoblasts cytology, Receptors, Notch metabolism, Signal Transduction
- Abstract
Postnatal bone marrow houses mesenchymal progenitor cells that are osteoblast precursors. These cells have established therapeutic potential, but they are difficult to maintain and expand in vitro, presumably because little is known about the mechanisms controlling their fate decisions. To investigate the potential role of Notch signaling in osteoblastogenesis, we used conditional alleles to genetically remove components of the Notch signaling system during skeletal development. We found that disruption of Notch signaling in the limb skeletogenic mesenchyme markedly increased trabecular bone mass in adolescent mice. Notably, mesenchymal progenitors were undetectable in the bone marrow of mice with high bone mass. As a result, these mice developed severe osteopenia as they aged. Moreover, Notch signaling seemed to inhibit osteoblast differentiation through Hes or Hey proteins, which diminished Runx2 transcriptional activity via physical interaction. These results support a model wherein Notch signaling in bone marrow normally acts to maintain a pool of mesenchymal progenitors by suppressing osteoblast differentiation. Thus, mesenchymal progenitors may be expanded in vitro by activating the Notch pathway, whereas bone formation in vivo may be enhanced by transiently suppressing this pathway.
- Published
- 2008
- Full Text
- View/download PDF
47. M-CSF regulates the cytoskeleton via recruitment of a multimeric signaling complex to c-Fms Tyr-559/697/721.
- Author
-
Faccio R, Takeshita S, Colaianni G, Chappel J, Zallone A, Teitelbaum SL, and Ross FP
- Subjects
- Actin Cytoskeleton metabolism, Amino Acid Substitution, Animals, Cell Movement physiology, Cells, Cultured, Macrophage Colony-Stimulating Factor pharmacology, Macrophages cytology, Mice, Mice, Inbred C57BL, Mutagenesis, Site-Directed, Osteoclasts cytology, Osteoclasts metabolism, Phenylalanine genetics, Phosphatidylinositol 3-Kinases metabolism, Phosphorylation, Protein Structure, Tertiary, Proto-Oncogene Proteins c-cbl metabolism, Receptor, Macrophage Colony-Stimulating Factor chemistry, Receptor, Macrophage Colony-Stimulating Factor genetics, Tyrosine genetics, src-Family Kinases metabolism, Cytoskeleton metabolism, Macrophage Colony-Stimulating Factor metabolism, Macrophages metabolism, Receptor, Macrophage Colony-Stimulating Factor metabolism, Signal Transduction physiology
- Abstract
M-CSF is known to induce cytoskeletal reorganization in macrophages and osteoclasts by activation of phosphatidylinositol 3-kinase (PI3K) and c-Src, but the detailed mechanisms remain unclear. We find, unexpectedly, that tyrosine (Tyr) to phenylalanine (Phe) mutation of Tyr-721, the PI3K binding site in the M-CSF receptor c-Fms, fails to suppress cytoskeletal remodeling or actin ring formation. In contrast, mutation of c-Fms Tyr-559 to Phe blocks M-CSF-induced cytoskeletal reorganization by inhibiting formation of a Src Family Kinase SFK.c-Cbl.PI3K complex and the downstream activation of Vav3 and Rac, two key mediators of actin remodeling. Using an add-back approach in which specific Tyr residues are reinserted into c-Fms inactivated by the absence of all seven functionally important Tyr residues, we find that Tyr-559 is necessary but not sufficient to transduce M-CSF-dependent cytoskeletal reorganization. Furthermore, this same add-back approach identifies important roles for Tyr-697 and Tyr-721 in collaborating with Tyr-559 to recruit a multimeric signaling complex that can transduce signals from c-Fms to the actin cytoskeleton.
- Published
- 2007
- Full Text
- View/download PDF
48. c-Fms tyrosine 559 is a major mediator of M-CSF-induced proliferation of primary macrophages.
- Author
-
Takeshita S, Faccio R, Chappel J, Zheng L, Feng X, Weber JD, Teitelbaum SL, and Ross FP
- Subjects
- Amino Acid Substitution, Animals, Antimetabolites pharmacokinetics, Bromodeoxyuridine pharmacokinetics, Cell Division drug effects, Cell Division physiology, Cells, Cultured, Extracellular Signal-Regulated MAP Kinases metabolism, MAP Kinase Signaling System drug effects, MAP Kinase Signaling System physiology, Macrophage Colony-Stimulating Factor pharmacology, Mice, Mutant Chimeric Proteins genetics, Mutant Chimeric Proteins metabolism, Phenylalanine genetics, Phosphatidylinositol 3-Kinases metabolism, Phosphorylation, Protein Structure, Tertiary, Proto-Oncogene Proteins c-akt metabolism, Receptor, Macrophage Colony-Stimulating Factor chemistry, Type C Phospholipases metabolism, Tyrosine genetics, src-Family Kinases metabolism, Macrophage Colony-Stimulating Factor metabolism, Macrophages cytology, Macrophages metabolism, Receptor, Macrophage Colony-Stimulating Factor genetics, Receptor, Macrophage Colony-Stimulating Factor metabolism
- Abstract
The molecular mechanisms by which binding of monocyte/macrophage colony-stimulating factor to its receptor c-Fms promotes replication in primary macrophages are incompletely understood, as all previous studies involved overexpression of receptor mutants in transformed cells not endogenously expressing the receptor. To address this issue we retrovirally expressed, in bone marrow-derived macrophages, a chimeric receptor containing a range of tyrosine to phenylalanine mutations in the c-Fms cytoplasmic tail. We measured incorporation of bromodeoxyuridine as a marker of proliferation and phosphorylation of ERKs, Akt, and the receptor itself. Our data indicate that tyrosine 559 is the major mediator of receptor activation and cell death, intracellular signaling, and cell proliferation and that the tyrosine residues at positions 697 and 807 play lesser roles in these events. Importantly, we find that activation of the ERK and Akt pathways is necessary but not sufficient for induction of macrophage proliferation. Using specific small molecule inhibitors we find that a combination of the Src family kinase, phosphatidylinositol 3-kinase/Akt, phospholipase C, and ERK pathways mediates macrophage proliferation in response to M-CSF.
- Published
- 2007
- Full Text
- View/download PDF
49. Syk, c-Src, the alphavbeta3 integrin, and ITAM immunoreceptors, in concert, regulate osteoclastic bone resorption.
- Author
-
Zou W, Kitaura H, Reeve J, Long F, Tybulewicz VL, Shattil SJ, Ginsberg MH, Ross FP, and Teitelbaum SL
- Subjects
- Amino Acid Motifs, Animals, Bone Resorption pathology, Cell Differentiation, Chimera metabolism, Humans, Integrin alphaVbeta3 metabolism, Intracellular Signaling Peptides and Proteins genetics, Intracellular Signaling Peptides and Proteins metabolism, Mice, Molecular Sequence Data, Osteoclasts pathology, Osteoclasts physiology, Phosphorylation, Protein-Tyrosine Kinases genetics, Protein-Tyrosine Kinases metabolism, Proto-Oncogene Proteins pp60(c-src) metabolism, Receptors, Immunologic chemistry, Receptors, Immunologic metabolism, Sequence Alignment, Syk Kinase, Bone Resorption enzymology, Integrin alphaVbeta3 physiology, Intracellular Signaling Peptides and Proteins physiology, Osteoclasts enzymology, Protein-Tyrosine Kinases physiology, Proto-Oncogene Proteins pp60(c-src) physiology, Receptors, Immunologic physiology
- Abstract
In this study, we establish that the tyrosine kinase Syk is essential for osteoclast function in vitro and in vivo. Syk(-/-) osteoclasts fail to organize their cytoskeleton, and, as such, their bone-resorptive capacity is arrested. This defect results in increased skeletal mass in Syk(-/-) embryos and dampened basal and stimulated bone resorption in chimeric mice whose osteoclasts lack the kinase. The skeletal impact of Syk deficiency reflects diminished activity of the mature osteoclast and not impaired differentiation. Syk regulates bone resorption by its inclusion with the alpha v beta3 integrin and c-Src in a signaling complex, which is generated only when alpha v beta3 is activated. Upon integrin occupancy, c-Src phosphorylates Syk. Alpha v beta3-induced phosphorylation of Syk and the latter's capacity to associate with c-Src is mediated by the immunoreceptor tyrosine-based activation motif (ITAM) proteins Dap12 and FcRgamma. Thus, in conjunction with ITAM-bearing proteins, Syk, c-Src, and alpha v beta3 represent an essential signaling complex in the bone-resorbing osteoclast, and, therefore, each is a candidate therapeutic target.
- Published
- 2007
- Full Text
- View/download PDF
50. Beta3 integrin deficiency promotes cardiac hypertrophy and inflammation.
- Author
-
Ren J, Avery J, Zhao H, Schneider JG, Ross FP, and Muslin AJ
- Subjects
- Animals, Bone Marrow pathology, Bone Marrow Transplantation, Cardiomegaly genetics, Cardiomegaly mortality, Cardiomegaly pathology, Cardiomegaly physiopathology, Gene Expression Regulation, Developmental, Humans, Integrin alpha5 metabolism, Macrophages metabolism, Macrophages pathology, Mice, Mice, Knockout, Myocarditis genetics, Myocarditis mortality, Myocarditis pathology, Myocarditis physiopathology, Myocytes, Cardiac pathology, Protein Kinases biosynthesis, Bone Marrow metabolism, Cardiomegaly metabolism, Integrin beta3 genetics, Myocarditis metabolism, Myocytes, Cardiac metabolism
- Abstract
Cardiac hypertrophy commonly develops in response to pressure overload and is associated with increased mortality. Mechanical stress in the heart can result in the activation of transmembrane integrin alphabeta heterodimers that are expressed in cardiomyocytes. Once activated, integrins stimulate focal adhesion kinase, Grb2, c-src, and other signaling molecules to promote cardiomyocyte growth and gene expression. Mechanical stress can also promote cardiac inflammation that may be mediated, in part, by the activation of integrins expressed in blood-borne cells. To address the role of one integrin, beta(3), in the pathogenesis of cardiac hypertrophy, beta(3)(-/-) mice were examined. beta(3)(-/-) Mice developed moderate spontaneous cardiac hypertrophy associated with systolic and diastolic dysfunction, and these abnormalities were exacerbated by transverse aortic constriction. In addition, beta(3)(-/-) mice developed mild cardiac inflammation with infiltrating macrophages at baseline that was markedly worsened by pressure overload. Bone marrow transplantation experiments showed that blood-borne cells were at least partially responsible for the cardiac hypertrophy and inflammation observed in beta(3)(-/-) mice. These results suggest that alpha(v)beta(3) expression in bone marrow has a generalized suppressive effect on cardiac inflammation.
- Published
- 2007
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.